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Summary   
 
Objective  
Over the last decades, quality epidemiological studies have repeatedly shown that the 
prevalence of mental illness is substantial, but still largely under-recognised and under-
treated. Under-recognition in general health care might also explain the modest attention to 
possible detrimental effects of such illness in terms of disability and mortality, and the 
mechanisms it operates through, compared to similar issues in other important fields of public 
health.  
This thesis is based on three papers, all focusing on grave outcomes of two of the most 
common mental illnesses; anxiety and depression. First, we investigated empirically the 
contribution of psychiatric morbidity to the award of disability pensions. With the purpose of 
finding out if anxiety and depression are under-recognized as risk factors for disability 
pension award, we examined if they had an effect independent of awards for physical 
diagnoses. Effects of mental disorders on disability pension award are generally estimated by 
aggregation of diagnoses reported in medical certificates underlying applications for disability 
pension, which is vulnerable for biases including the above mentioned under-recognition of 
mental disorders.  
 10 
There are numerous reports of effects of depression on general mortality, and 
specifically for cardiovascular diseases (CVD) and suicide. The second and third papers 
address six uncertainties in this literature concerning (i) residual confounding, (ii) dose-
response effect of severity of depression, (iii) mechanisms driving the association, (iv) 
whether there is an effect of mortality beyond CVD and suicide, (v) effect-moderation by 
gender, and (vi) effect of comorbid anxiety.  
 
Method  
For all three papers we used historical cohort designs utilizing unique links between a large 
epidemiological cohort study and comprehensive national databases of disability pension 
award and mortality. Baseline information on mental and physical health was gathered from 
the population-based health study of Nord-Trøndelag County in Norway in 1995-97 (the 
HUNT-2 study), aiming at including the entire population aged 20 years and older. 
Addressing mortality, 61 349 individuals were eligible for inclusion, restricted to 45 782 
individuals within working age (20-66 years) not already claiming disability pension in 
analyzing work-related disability. Anxiety and depressive symptoms were ascertained using 
the Hospital Anxiety and Depression Scale (HADS). Possibly confounding and mediating 
factors included somatic symptoms and conditions, health-related behaviour, subjective 
impairment, and socio-economic factors. In the first paper, the outcome was the award of 
disability pension within a 2 year follow up, as registered by the eliciting ICD-10 diagnoses in 
the National Insurance Administration. For the second and third paper, general mortality and 
cause specific mortality registered with ICD-10 diagnoses during 4.4 year follow-up were 
outcomes, respectively.  
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Results  
From the first paper it is concluded that anxiety and depression are robust predictors of award 
of disability pensions in general, even when disability pensions awarded for any mental 
disorder (any F-diagnosis) were excluded. These effects were only partly explained by 
baseline somatic symptoms and diagnoses. Somatic symptoms accounted for far more awards 
of disability pensions than somatic diagnoses. The effect of anxiety and depression on 
disability pension award was equally strong in men and women, but stronger in younger sub-
groups than older.  
In the second and third paper, (i) depression was found to have an independent effect 
on general mortality. (ii) We found a dose-response association between severity of 
depression and mortality within the clinical range of the distribution. (iii) As to underlying 
mechanisms involved; factors not accounting for the association included body mass index 
(BMI), cholesterol level, and blood pressure, whereas educational level and health related 
behaviour accounted for a marginal proportion of the effect. Adjustment for somatic 
conditions was the strongest single contributor to explain the association, followed by 
subjective physical impairment and somatic symptoms. (iv) The effect of depression was 
equally strong on cardiac mortality as on all other causes of mortality combined, and 
confounding factors were also markedly similar. Depression predicted disease-mortality 
beyond CVD, and also accidents and mortality with uncertainty as to diagnoses. (v) There 
was no effect moderation by gender, but the effect of depression on mortality was stronger in 
younger individuals than older. (vi) Anxiety comorbid with depression was associated with 
lower mortality than in depression alone. We found no effect of case-level anxiety beyond the 
effect of comorbid case-level depression. Expanding the analysis beyond case-levels, we 
found a U-shaped and slightly negative effect of anxiety on mortality. 
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Conclusions  
Anxiety and depression do predict grave outcomes like disability pension and mortality.  
The effect of anxiety and depression on disability pension awarded for non-psychiatric 
diagnoses indicates that the cost of common mental disorders in terms of disability pension 
expenditure and lost productivity may have been considerably underestimated by official 
statistics. We suggest this might be due both to over-use of physical diagnoses and under-
recognition of common mental disorders in primary care.  
 The two mortality papers contribute to the existing literature in several ways: (i) We 
conclude that the effect of depression on mortality is not an artefact from residual 
confounding. (ii) Contrary to conclusions from reviews and meta analyses, we find a dose-
response association between symptom load of depression and mortality within the clinical 
range of the distribution. (iii) We dismiss some candidate explanations on mechanisms 
underlying the association (including the biological factors examined). (iv) Our finding of 
effects of depression beyond CVD mortality and suicide has consequences and should spur 
generation of new hypotheses on mechanisms underlying the association. (v) The evidence for 
effect moderation by gender in the association between mortality and depression is weak (but 
the hypothesis seems long-lived), and our findings indicate that it should be put to rest. (vi) 
The findings on the effect of anxiety were contrary to our expectations, and needs 
replications, and further examinations of underlying mechanisms.  
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1 Background  
Health screenings for the major health problems tuberculosis and cardiovascular diseases in 
the general population have a long tradition in Norway. The initial aim of these studies was to 
screen for individuals who needed medical treatment, but the primary aim has in later days 
shifted towards research purposes. During the last decades, mental health problems have 
gradually received a more prominent status as a major health problem, and measures of 
symptoms on common mental disorders were therefore included in the surveys (1).  
The present dissertation explores hypothesized effects of two of the most common 
mental disorders; anxiety and depression on mortality and work-related disability and possible 
mechanisms in this relation. The base-line measures were collected from the largest general 
health survey in Norway, the HUNT-2 study, where approximately 62 000 individuals aged 
20 years and older participated. Dependent variables were identified in national registries, and 
the data resources were merged by the national personal identification number.  
The background is organized in five sub-chapters: First, the epidemiology of the 
exposures (anxiety and depression) will be presented. Second, a three-dimensional model for 
measuring health including mental health, physical health, and somatic symptoms will be 
presented. Third, the outcomes of the studies; disability pension award and mortality will be 
described, and finally the aims of the studies will be presented in detail.  
 
1.1 The descriptive epidemiology of mental health  
1.1.1 Prevalence of mental disorders  
Anxiety and depression are common disorders in the general population. In the U.S. 
Epidemiological Catchment Area (ECA) study in the early 1980s, the 12-month prevalence of 
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any diagnosable DSM-III disorder was 29.4% (2). The Diagnostic Interview Schedule (DIS) 
which was used in the ECA, was developed by the National Institute of Mental Health for the 
purpose of screening for mental disorders by interviewers who not necessarily had to be 
trained psychiatrists or psychologists (3).  
The probably best study of prevalences of mental disorders is the National 
Comorbidity Survey (NCS) (4) was conducted by Ronald Kessler and collaborators in the late 
1980s. This study included an evaluation of parental psychopathology, family problems, 
social networks, and external stress, and was based on a random sample of 8,090 subjects 
between 15 and 54 years, excluding institutionalized individuals. The response rate was 
82.6% (5). In the NCS, mental disorders were screened with a modified version of the 
Composite International Diagnostic Interview (6). This is a structured instrument combining 
aspects of the DIS and the Present State Examination, and was designed for use by trained lay 
interviewers (7). Through use of the DSM-III-R criteria, the 12-month prevalence of any 
mental disorder in this study was 29.4% in men and 32.3% in women, whereas the lifetime 
prevalence was 51.2% and 48.5% respectively. Both affective disorders and anxiety disorders 
were found to be more prevalent among women, whereas addictions were more prevalent 
among men. The 12-month prevalence of anxiety disorders was 24.7% in women and 13.4% 
in men, and affective disorders were found among 14.1% of women and 8.5% of men. 
Addiction was found among 6.6% of women and 16.1% of men (8).  
 A Norwegian study, modelling the NCS was carried out by Kringlen and collaborators 
in Oslo in 1994-97 (7). The prevalence of mental disorders, and also the gender ratios, was in 
Norway found to be very similar to those found in the NCS, the exception being the 
prevalence of addiction, which was less prevalent in the Oslo sample.  
 The NCS prevalence estimates of mental disorders in the U.S. population (8) have 
been questioned for being too high, and thus being of little clinical relevance (9). Other 
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prevalence estimates have been proposed also including clinical significance criteria of mental 
disorders; self-reported use of health services, medication, or impairment (10). By employing 
such approaches, the prevalence estimates were, not surprisingly, lower with a 12-month 
prevalence of anxiety or depression at 14.9%. The 12-month prevalence of any anxiety 
disorder was 11.8% and of major depressive episode 4.5%. Phobias (4.3%) were the most 
prevalent within the anxiety disorders, followed by posttraumatic stress disorder (3.6%), 
social phobia (3.2%), generalized anxiety disorder (2.8%), agoraphobia (2.1%), obsessive-
compulsive disorder (2.1%), and panic disorder (1.4%). These suggestions for revisions of 
definitions of mental disorders (and consequently lower prevalences) have later been 
abandoned (11). 
 A replication of the NCS (NCS-R) was conducted from 2001 through 2003. It was, 
like the first one, organized as a face-to-face interview, and diagnoses were coded according 
to DSM-IV. The 12-month prevalence of any mental disorder was 26.2%. In detail, the 12-
month prevalence for anxiety was 18.1%, 9.5% mood disorder, 8.9% impulse control, and 
3.8% substance abuse. Of the cases in the study, 22.3% were classified as serious; 37.3% 
moderate; and 40.4% as mild. Fifty-five percent carried only a single diagnosis; 22% 2 
diagnoses, and 23% carried 3 or more diagnoses. The authors concluded that although mental 
disorders are widespread, serious cases are concentrated among a relatively small proportion 
of cases where comorbidity between disorders is common (12). The lifetime prevalence of 
any DSM-IV disorder was 46.4%, mainly distributed as anxiety disorders 28.8%, mood 
disorders 20.8%, impulse-control disorders 24.8% and substance use disorders 14.6%. Median 
age of onset was lower in anxiety and impulse control disorders (both 11 years) than for 
substance use (20 years) and mood (30 years) disorders. Half of lifetime cases of mental 
disorders started by age 14 and three fourths by age 24 (13). Consequently, the authors 
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concluded that interventions aimed at prevention or early treatment must be focused on 
adolescents.  
 
1.1.2 Anxiety and depression have severe consequences for both the 
society and for the individual  
Mental illnesses commonly have a long-lasting or chronic course with recoveries and 
relapses, and have serious consequences for both the society and for the individual. The 
Global Burden of Disease Study concluded that depression is the single diagnosis that causes 
the highest number of lost healthy years in the western world (14). Worldwide, depression 
was ranked as the fourth most important specific cause of global disability-adjusted life years 
(DALY, sum of life years lost due to premature mortality, and years lived with disability 
adjusted for severity) (15), and was predicted to advance to the second most important cause 
by year 2020 (16). These estimates have been much debated as to methodology in general, 
and the epidemiological knowledge underlying the estimates (17). It has been suggested that 
the impact of major depression and substance disorder are overestimated at the expense of 
anxiety disorders (18).   
Depression is also reported to increase general mortality (19), CVD mortality (20-23), 
suicide (24), and other non-illness causes of death (25-27). In addition to individual 
consequences, depression in mothers has consequences for development among children, 
especially when children are young (28), and mental disorders, and depression in particular, is 
a risk factor for divorce (29). It has societal consequences in that mental disorders, most often 
depression, is the primary medical diagnosis in 30% of awards of disability pension (30), 
depression causes considerable economic loss for employers, and the cost in terms of lowered 
productivity accounts for more economically than sickness absence (31, 32).  
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 For the anxiety disorders, corresponding figures or estimates are scarce. In addition to 
depression, all common physical diagnoses were included in the rankings in the Global 
Burden of Disease Study (14), but anxiety disorders were not included. However, analyses 
from the NCS suggest the annual costs of anxiety disorders similar to the total costs of 
affective disorders (33).  
 
1.1.3 Dimensional and discrete approaches to measurement of anxiety 
and depression  
In mental health research, anxiety and depression are represented both by continuous and 
discrete measures. In clinical practice, the discrete approach has been the most influential, 
largely because it is a premise of the commonly accepted diagnostic manuals DSM-IV (34) 
and ICD-10 (35). For research purposes, the discrete approach can be compelling as it eases 
the transition from research to applied knowledge amongst clinicians. But for both clinical- 
and research purposes it is important to keep in mind the limitations of the categorical models:  
Diagnostic classifications are reached by consensus in expert panels, and the 
diagnostic entities are continuously subjects to change and revision. These diagnostic 
instruments must be regarded as social constructions rather than true descriptions of aspects of 
reality. The discontinuity model may be useful in clinical settings and even serve important 
purposes in research, but over time, present cut-offs and demarcations may appear arbitrary. It 
is important to be aware of the limitations of the diagnostic systems.  
Furthermore, mental disorders are dimensional rather than discrete by nature. The 
actual distribution of symptoms of anxiety and depression in the general population are best 
represented as a continuum from low to high symptom load (that is, from every degree of 
good mental health to different levels of psychopathology) with corresponding lower 
prevalences in the general population (Figure 1). There is a dose-response relationship 
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between the number of symptoms of depression, the frequency and the duration of depressive 
episodes, and indicators of diagnostically acknowledged depression (36). In the dominant 
diagnostic manuals, a mental disorder is simply a mental symptom load above a certain 
threshold, although in ICD-10 and DSM-IV, symptoms are weighted such that some criteria 
are obligatory and others additional. Still, the number of additional criteria needed for a 
diagnosis applies a cut-off on a continuum, and the weighting system may be subject to 
revision in future diagnostic manuals. The thresholds for case-levels might not only be only 
arbitrary, but sub-threshold "conditions" (defined as individuals with a defined symptom-
range immediately below case-level for a mental diagnosis) have repeatedly been found to 
have significant clinical impact in terms of for example functional work-related impairment 
(37). Among elderly with high loads of depressive symptoms, few fulfil DSM criteria for 
affective disorders, but many cases with sub-threshold depression were found to be chronic or 
fluctuating over a 6-year period in a Dutch prospective community based study (38).  
As a property of the distribution, most suggested analyses identify a larger group of 
individuals within the sub-threshold range than on clinical levels. As a consequence, the sub-
threshold cases accumulate more adverse outcomes than case-levels, even if the risk 
associated with sub-threshold case-levels commonly are lower than for case-levels (37). 
Individuals with symptom loads within the sub-threshold level of psychiatric morbidity are 
also reported to be in need of mental health care (39). Simply lowering the diagnostic 
threshold does not solve the problem of categorization (40), and the suggestion that anxiety 
and depression are dimensional phenomena with no thresholds between pathology and 
normality (41) is plausible, and the use of continuous symptom scores is suggested as an 
alternative to discrete measures in measuring and describing mental symptoms (42). Recent 
evidence, mainly provided by Jim van Os' group, suggests this continuum model for mental 
disorders also applies to schizophrenia (43, 44). The perhaps most convincing argument 
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offered by this group is that common symptoms in schizophrenia, for example hallucinations, 
also occur in healthy individuals and individuals with anxiety and depression (43). 
 
 
  
The use of discrete diagnostic entities with cut-offs for case-levels in diagnostic manuals are 
motivated by ideals from bio-medical models. It can be argued that discrete diagnostic entities 
are useful for decision-making in clinical practice (in offering indications for treatment), and 
also on a policy level (in planning and establishing services). This argument is, however, 
precluded by that most individuals who fulfil diagnostic criteria for a mental disorder will not 
seek treatment (45). There is a large discrepancy between the prevalence of mental disorders 
and treatments for them in the general population, but this does not imply that everybody with 
a mental disorder is in need of treatment (46). The perhaps best argument for employing 
discrete measures of mental symptoms based on ICD-10 and DSM-IV for clinical purposes 
and research is that a common terminology can stimulate communication, recognition, 
research and development: It can be held that it is easier to communicate a prevalence of a 
mental disorder than a left-skewed normal-distribution of mental symptoms, and relative risks 
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between two groups compared to a standardized regression coefficient of continuous 
measures (perhaps even based on log-transformed variables).  
 Finally, use of discrete measures in describing mental disorders relate to the problem 
of comorbidity. Most mental symptoms are co-occurring, anxiety and depression in particular 
(5). Commonly, individuals have sub-threshold levels of both anxiety and depression, 
resulting in a high total symptom-load, despite being below the diagnostic levels of both 
diagnoses (41). 
 
1.1.4 Comorbidity between anxiety and depression  
As mentioned above, most mental disorders are associated, and this also applies to anxiety 
disorders and depression (5, 47). Embedded in the term “comorbidity” is use of a discrete 
diagnostic system. Alternatively, the term co-dimensionality has been suggested to describe 
this within a dimensional approach (41). Comorbidity between any two diagnoses is present if 
their co-occurrence is more frequent than by chance (48). It can be objected that the 
comorbiditiy between mental disorders simply are artefacts of separating what essentially is 
nosological entities (41). The comorbidity between anxiety and depression can be described 
both as diagnostic comorbidity, that is some diagnostic criteria are shared, and pathogenic 
comorbidity, e.g. that depression commonly follows anxiety (41).  
 In the previously described NCS-study, the comorbidity between 12-month prevalence 
of any anxiety disorder and major depressive disorder (MDD) was 51% (47), but estimates 
across studies vary. The association between mental symptoms has also been described as 
correlations between continuous measures. Employing HADS (49) in the HUNT study, 
anxiety and depression was reported to share 30% of the variance, which is within the range 
of correlations with this instrument (24-40%) previously reported (50).  
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 Several publications have addressed properties of the comorbidity between anxiety 
disorders and depression. Comorbid anxiety and depression implies poorer treatment response 
to antidepressive medication (51), lower rate of recovery from depression, increased time 
from debut till recovery, decreased time from remission to relapse (52, 53), and increases risk 
of suicide (54) than when anxiety disorders or depression occur alone. As comorbid anxiety 
and depression in the discrete approach implies having two mental disorders rather than one, 
comorbid conditions can be expected to entail more adverse outcomes (55). Employing the 
screening instrument HADS, comorbidity is defined as a score above case-level (56) on both 
sub-scales (57), and with few exceptions, the association between somatic health problems 
(e.g. myocardial infarction, diabetes, migraine, fibromyalgia and muscle-skeletal complaints) 
and comorbid anxiety depression was reported to be stronger than in anxiety or depression 
alone (57). It can be objected to these findings of worse outcomes in (and correlates to) 
comorbid anxiety depression than pure cases that they may be driven from the higher 
symptom-load in comorbidity rather than the qualitative nature of comorbid symptoms alone.  
 
1.1.5 Anxiety and depression – one or two dimensions?  
The strong correlation between anxiety and depression that is observed using screening 
instruments (50), and comorbidity rates between anxiety disorders and major depression in 
surveys like NCS (5) and the Oslo study (7) may indicate that anxiety and depression should 
be considered a uni-dimensional scale rather than two separate dimensions. The screening 
instrument HADS is appropriate for examining this hypothesis as it contains symptoms of 
both anxiety and depression, and multiple factor analyses have been performed both in 
clinical samples and samples from the general population. Support for a uni-dimensional 
model for both anxiety and depression was reported from a Belgian cancer population (58), 
whereas Moorey et al suggested a two-dimensional model after analyses of a sample of 
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British cancer patients (59). The two-factor solution is also confirmed in the Norwegian 
translation (50). Objections to this two-factor solution were after this publication proposed by 
authors examining the factor structure in a sample of inpatients (60), but this and other 
deviations from the original two-factor solutions are probably due to restraints of the variance 
in either (or both) sub-scales resulting from inclusion of severely mentally ill patients in the 
samples examined only (61). The debate whether anxiety and depression are one or two 
dimensions by nature will probably continue.  
 
1.1.6 Is the prevalence of mental disorders increasing?  
An increase in the prevalence of common mental disorders among adults is commonly 
hypothesized, perhaps justified by an increasing attention to mental disorders in the media and 
in the public, as well as a strong increase in use of psychotropic medication for depression in 
USA, which was reported to triple from 1987 to 1997 (62). There was, however, no increase 
in outpatient psychotherapy use (63).  
For several reasons, trends in the prevalence of mental disorders are difficult to 
address empirically: The history of measuring common mental disorders, both through 
dimensional screening instruments or discrete diagnostic measures, is short. Due to 
differences in measurements, it is difficult to compare prevalence estimates of mental 
disorders further back in history than the introduction of DSM-III-R. Even if instruments were 
corresponding, the meaning of words and phrases might change over time from changes in 
culture and language. Lastly, psychiatric epidemiology is a relatively novel discipline, and 
there are few empirical studies on prevalences of mental disorders to be replicated in modern 
time for comparison.  
 The ECA and NCS studies are probably the best empirical basis for evaluation of 
trends in prevalence of mental disorders. As mentioned above, the 12-month prevalence of 
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any DSM-III disorder in the ECA was 29.4% in the 1980s (2). A decade later, the 12-month 
prevalence of any DSM-III-R disorder was 30.5% (5) among people 15 to 54 years of age. 
The NCS replication conducted in 2001 through 2003 found a 12-month prevalence of 30.5% 
of any DSM-IV diagnosis, which compares to 29.4% in the NCS in 1990-92 (p=.052) 
(numbers are NCS estimations recalculated from DSM-III-R to DSM-IV for the purpose of 
comparison) (11). Further, there was no significant change in the prevalence of serious 
disorders (5.3% vs. 6.3%, p=.027), moderate disorders (12.3% vs. 13.5%, p=.030), and mild 
disorders (11.8% vs. 10.8%, p=.037), and there was no statistically significant interaction 
between time and any socio-demographic characteristic in the prediction of prevalence (11).  
 In conclusion, there is no evidence for any increase in the prevalence of mental 
disorders in the USA from the 1980s. Any changes from longer back cannot be ruled out. 
Whether these US findings can be generalized to European or Norwegian populations can 
obviously be questioned.  
 
1.2 Three main dimensions in the measurement of health: Mental 
health, physical conditions1, and somatic symptoms  
The relationship between mental and physical health is complex: Mental health problems 
might cause somatic disease, e.g. depression being a risk factor for CVD (64), somatic 
diseases may cause or aggravate the mental health (65), a mental health problem can be 
prodrome of a physical disorder not yet diagnosed, e.g. depression being a prodrome of 
dementia (66). Furthermore, there may also be some common pathophysiological mechanisms 
underlying both mental disorders and somatic disease (65) and reciprocal relationships 
between depression and somatic health problems are reported (67).  
                                                 
1 The terms physical conditions, somatic conditions, somatic diagnoses and somatic diseases are used as 
synonyms throughout the text.   
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Increased prevalence of anxiety and depression is reported in almost all physical 
diseases. This is demonstrated in studies based on the general population (5, 57, 68), among 
patients in general practice, and in numerous studies of specific physical disorders, like CVD, 
which is one of the physical conditions most frequently reported to be associated with mental 
disorders in general, and depression in particular (41).  
Associations between physical health and depressive symptoms in later life are found 
to be consistent across Western Europe (69).  
The HUNT study is suitable for examining these hypotheses as it is based on the 
general population, and includes multiple variables on physical conditions in addition to 
measures of anxiety and depression. Examples of studies reporting increased prevalences of 
anxiety and depression in somatic conditions are numerous, and include the HUNT studies of 
e.g. myocardial infarction (70) and migraine (71). Reports of absent associations between 
anxiety or depression and physical diseases are uncommon in well-powered studies, and do 
from the HUNT study include studies of thyroid dysfunction (72, 73) and Type-2 diabetes 
(adjusted for comorbid physical conditions and complaints) (74). The latter finding is also 
reported in a Dutch community-based study (75). Increasing prevalence of physical symptoms 
and conditions with age (76) is in the HUNT study reported to account for some of the 
increase in depression by age (77).  
 The more complex issue, however, is the area of somatic symptoms without any 
known organic aetiology, labelled somatization, somatoform disorders, medically unexplained 
symptoms, or functional somatic symptoms (78). Such symptoms might be related both to 
physical conditions as described for mental disorders above, and are also related to mental 
disorders, partly as vegetative symptoms that define mental disorders like depression (35), but 
also co-occurring more frequent than by chance. From the HUNT study, comorbidity with 
anxiety and/ or depression is reported for gastrointestinal complaints (79, 80), for 
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psychosomatic symptoms in general (81), and to subjective impairment attributed to physical 
conditions (57).  
 There exists a more or less subtle conflict between the mental and somatic health 
professions as to how somatic symptoms shall be interpreted. From a mental health 
perspective, somatic symptoms with unclear or absent organic aetiology can be interpreted as 
somatic symptoms in e.g. depression. If symptoms are spread over multiple organ systems, 
persist over time, and proper examinations have revealed no organic aetiology, the diagnosis 
somatization disorder (ICD-10 diagnosis F45.0) might be relevant.  
Patients with common psychiatric disorders such as anxiety and depression frequently 
present to their doctors with medically unexplained physical symptoms (82), which in cases 
without organic aetiology have been labelled "somatization". However, patients with 
medically unexplained somatic symptoms do often not have psychiatric disorders, and the 
symptoms might rather indicate minor pathological change, physiological perceptions, and 
other factors including previous experience of illness (83). Comparing physicians' initial 
assessment of the nature of symptoms and their final diagnosis, Nimnuan et. al. concluded 
that physicians were more likely to error on the side of diagnosing the symptoms as medically 
explained rather than unexplained (83). Further, when physicians perceived the interaction 
with the patient to be positive, they were more likely to make provisional diagnosis that an 
explanation of the symptoms were identified, and conversely, negative perceptions of 
interactions more often increased likelihood of viewing symptoms as medically unexplained.  
 The proportion of medically unexplained symptoms presented in both general practice 
and in various specialist disciplines are perhaps surprisingly high given their strong focus on 
biomedical models. In one study, the proportion of consultations where organic aetiology was 
concluded ranged between 10 and 25% across symptoms (chest pain 12%, fatigue 17%, 
dizziness 19%, headache 11%, back pain 10%, dyspnoea 25%, abdominal pain 10%, and 
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numbness 20%) (84). The proportion of patients with medically unexplained symptoms in 
medical specialised clinics is also high, overall as high as 56% (95% confidence interval 52-
60), and varying in one study from 49% (95% confidence interval 37-61) in dental clinics to 
60% (95% confidence interval 45-73) in gastroenterology (85). The authors concluded that 
medically unexplained symptoms are common across general and internal medicine, and 
represent the most common diagnosis in some specialities. They further found that psychiatric 
morbidity was not per se associated with the presence of medically unexplained symptoms, 
but was more likely in those complaining of multiple symptoms. In this epidemiological 
study, patients with medically unexplained symptoms were more likely to attribute their 
illness to physical causes than lifestyle factors.  
 Medically unexplained somatic symptoms have serious consequences (78). In UK 
primary care they account for 35% of all consultations in primary care (medically unexplained 
symptoms being main clinical problem) (86). Chronic fatigue syndrome is associated with 
worse disability than conditions such as heart failure (87). The prevalence of emotional 
disorders is higher in patients with functional syndromes than in patients with comparable 
medical conditions (88).  
 From the perspective of psychiatry, the development and marketing of e.g. the 
diagnosis chronic fatigue syndrome is suspected to be “old wine in new bottles”. Both chronic 
fatigue and chronic fatigue syndrome are common among primary care patients and represent 
a considerable public health challenge (89). Most subjects with chronic fatigue or chronic 
fatigue syndrome in primary care also meet criteria for current psychiatric disorders, and both 
are associated with previous psychiatric morbidity. The symptoms are thought to represent a 
specific process in chronic fatigue syndrome that may be related to the joint experience of 
somatic and psychological distress (90).  
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Disputes around the medically unexplained symptoms are indeed an issue where not 
only mental and somatic specialities struggle; also medical specialities beyond psychiatry 
have their own claims of understanding these patients. It is even suggested that patients with 
medically unexplained symptoms are given diagnoses dependent upon the particular medical 
speciality consulted (91, 92). One suggested list of syndromes by speciality includes irritable 
bowel syndrome (or non-ulcer dyspepsia) in gastroenterology, premenstrual syndrome or 
chronic pelvic pain in gynaecology, fibromyalgia in rheumatology, atypical or non-cardiac 
chest pain in cardiology, hyperventilation syndrome in respiratory medicine, chronic 
(postviral) fatigue syndrome in infectious diseases, tension headache in neurology, 
temporomandibular joint dysfunction and atypical facial pain in dentistry, globus syndrome 
among ear, nose, and throat specialists, and multiple chemical sensitivity in allergy (78). 
Factor analyses of symptoms presented by consecutive new patients across seven outpatient 
clinics suggested that the existence of distinct functional somatic syndromes as defined 
clinically in medicine should be reconsidered (91).  
Wessely and collaborators argue that the existence of specific somatic syndromes is 
largely an artefact of medical specialization (78), after having  found overlap in case 
definitions across specific syndromes and that the patients with one functional syndrome 
frequently met diagnostic criteria for other functional syndromes. Furthermore, they found 
that different functional syndromes frequently shared non-symptom characteristics, and that 
different functional syndromes responded to the same therapies. It is concluded that existing 
definitions that claim these symptoms to point to specific syndromes is of limited value, and 
could be replaced with a dimensional classification (78).  
 The debate on ways to define unexplained somatic symptoms (either they are labelled 
as functional disorders or not) is relevant for psychiatric epidemiology in several respects: 
Somatic symptoms are legitimate symptoms of both mental and physical diagnoses (not 
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including the functional ones). For the case of depression, employment of standard diagnostic 
tools for mental disorders like ICD-10 (35) or screening instruments like Centre for 
Epidemiological Studies – Depression (CES-D) (93) or Beck Depression Inventory (BDI) 
(94) might bias the measurements in direction of false positive cases in individuals suffering 
from physical conditions. This because most instruments measuring depression include items 
on poor appetite, disturbed sleep, somatic preoccupation, or weight loss, which are not only 
sensitive to depression, but also a whole range of physical disorders in addition to 
unexplained medical symptoms. Often statistical strategies are applied to avoid this bias in 
models both where mental health is a dependent or an independent variable. Such strategies 
include adjustments for the presence of possible physical diseases and somatic symptoms. A 
different approach is evident employing the HADS that does not include somatic items to in 
this vein attempt to avoid false positive cases from co-occurring somatic conditions (49). As 
the name implies, the instrument was originally developed for use in a setting where such 
somatic symptoms are abundant. This last strategy does, however, bias the results in the 
opposite direction; in under-estimating the correlate to mental disorders of interest. Among 
the two possible biases described here, the latter seems to be the most acceptable in the 
scientific medical community and journals in general, and also in psychiatry, perhaps a 
reflection of the balance of power between mental and physical health professions?  
 It might be fair to claim there is a hierarchy from somatic conditions on top via 
somatic symptoms till mental disorders. This is illustrated by echoing Eaton (95, referred in 
96): "Epidemiology is a branch of medicine, and thus the assumptions of the medical model 
of disease are implicit. The most important assumption is that the disease under study actually 
exists […] In psychiatry this assumption is assured more tenuous than in other areas of 
medicine, because psychiatric diseases tend to be defined by failure to locate a physical cause 
…"   
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1.3 Disability pension  
In Norway in the 1990s and up to 2004, disability pension is awarded to any individual within 
working age whose workability is permanently deteriorated, and where the cause is a medical 
diagnosable condition (mental or physical). The arrangements differ across countries, but 
most countries within the Organization of Economic Cooperation and Development (OECD) 
have arrangements for long-term or permanent occupational disability (97). For ease of 
international comparison, disability pension can be regarded as a kind of long-term sickness 
absence.  
A recent and thorough literature review of sickness absence and disability pension 
award (98) concluded that despite the public focus on sickness absence and its major impact 
on society and the individual, there is limited knowledge about the causes and consequences, 
and how they can be influenced. Further, the review concluded that the field of sickness 
absence research is underdeveloped in terms of theory, methodology, and concepts and that 
several research questions raised today still are very general in nature. As such, current 
research and the present knowledge base does not provide physicians, insurance officers, 
employers, labour unions, and politicians with the necessary insight for improved decision-
making. The authors of the review list surprisingly few studies on causes and consequences of 
sick leave and on physicians' sickness certification practices, and only few of these are of high 
methodological quality (99). For disability pensioning, only 18 studies with sufficient quality 
for inclusion in a review were identified (100). There is therefore a demand for longitudinal 
studies of causes of disability pension of good methodological quality (99, 101). A majority 
of previous studies were undertaken in Finland (e.g. 102, 103, 104), Sweden (e.g. 98, 105), or 
Great Britain (e.g. 106). American studies are commonly based on either work-place samples 
(e.g. 31) or for example data from the NCS (e.g. 107). There is also some research in this area 
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in Norway, in particular studies based on sociological or economic perspectives, but 
unfortunately, much of it is published in Norwegian only (e.g. 108, 109).   
 
1.3.1 Consequences of disability pensioning for the society  
Early age occupational disability is a burden to society, both in terms of expenses from direct 
costs to disability pensions, but also due to lost productivity and income taxes. At the end of 
2004, there were 302,369 permanent disability pensioners in Norway and additional 8515 on 
time-limited disability pension (according to revised rules for award of disability pension) 
(30). Disability expenditure accounts for a significant proportion of Gross Domestic Products 
(GDP) across Europe, varying from about 1% in Ireland to 5% of GDP in Norway (97). The 
direct expenses to permanent disability pensions were in 2004 Norwegian Kroner (NOK) 
41,060,000,000 and accounts for 18% of the total expenses to social security in Norway (30). 
The increase in direct expenses to permanent disability pensions from year 2000 till 2004 is 
25% (both NOK in 2004 values) (30).  
 The number of individuals on sick leave and disability pension has in the OECD 
region increased dramatically in recent years, which translates into major economic costs and, 
and potentially also long-term consequences for the design of welfare state (110). Combined 
with a change in demographic distribution towards the higher age cohorts and no change in 
mean age retirement, the proportion of the population working and providing for the rest is 
decreasing dramatically. An increased rate of disability pension award adds to this financial 
problem for the society. At the end of year 2004, 12.0% of the total population aged 18 to 67 
years were recipients of disability pension (173 012 of 1 437 209 individuals). Return to work 
from disability pension is uncommon: In 2004, exits from disability pension were due to 
receipt of other kind of pension (74.4%), mortality (18.4%), and other causes (7.2%) (30), and 
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the exit from disability pension was less than 1% in Norway in 1995, which is at the very 
lowest level among OECD countries (97).  
 
1.3.2 Consequences of being on disability pension  
It is claimed that sick listing, through processes like isolation, stigma and loss of work-role, 
may have serious negative individual consequences (111), and that physicians should be more 
restrictive in issuing sickness certificates. An alternative position suggests that becoming 
disability pensioner can be an attractive position for the individual, as it may imply relief from 
work-related strains and burdens, and also relief from financial worry. A recent publication 
utilizing the British household panel survey revealed increased psychological distress 
corresponding to transitions from paid employment to unemployment or long term sick leave, 
and also associations between improvement in psychological distress and moving from non-
employed roles into formal employment (112). A review of available literature in English and 
Scandinavian languages published in 2004 reported a lack of scientific studies in this area, 
and also that scientific studies seldom were referred in this debate (110). The 3rd pre-
conference meeting on sickness absence at the European Association of Public Health 
Association's (EUPHA) conference in Graz (November 9th 2005) on research on health 
consequences of sickness absence and disability pension landed on the same conclusion.  
 
1.3.3 The physicians' role in the process of disability pensioning and 
sick-listing  
In Norway and several other European countries, applications for disability pension must be 
issued by a physician certifying to the presence of a diagnosable sickness or injury that 
permanently impairs the patient's ability to undertake any feasible work. Over the years, the 
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certificates have taken various forms, but the key information requested has always been 
related to the patient's diagnoses and work ability (110).  
The physician has six roles in the process of sick-listing (113): (a) Determine if the 
disease or injury is present according to existing criteria; (b) and if it implies impaired ability 
to work. Currently, in Norway, more than 50% impairment is necessary for award of 
disability pension. (c) Further, advantages and disadvantages of sick leave must be considered 
in dialogue with the patient, (d) the grade and duration of sick leave must be determined (e) as 
must also need for contact with specialists, the social insurance office, or other parties. (f) 
Finally, the standard certificate must be completed.  
 The physicians' role in the process of disability pensioning is a balance between being 
the patient's advocate and being a gate-keeper restricting the access to public generous (and 
expensive) welfare systems (113). According to formalities, the physician is supposed to 
decide on workability and eventual diagnosis based on examinations of the patient. Already in 
the 1960s, the information imbalance in the patient-doctor dyad was evident: "Examining by 
the doctor is usually a meaningless formality, since it is the patient who decides when he is fit 
for work" (114).  
 Both physicians and patients raise the question of sick leave in consultations, and 
physicians do almost always issue sick leave certificates when requested by the patient (113, 
115). To the best of our knowledge, no such study exists for disability pension. Physicians 
generally find the issue of assessment of workability difficult (113). Patients and physicians 
usually agree on the need for sick leave (113), but a Swedish study on young immigrants 
suggests there is disagreement between physicians and external experts’ reviewing decisions, 
probably due to insufficient objectivity in the assessment (116). Certificates are often 
inadequately completed by the physicians (113). Physicians differ in their assessment of the 
need for sick leave, not only at the level of general practitioner (117, 118), but also between 
 37
geographic regions (119) and specialists (113, 120). Strong demands from the patient for the 
need for sick leave increase sick leave certification (120) and when physicians report good 
knowledge of the patient, the sick-leave increases (121). An explorative Norwegian analysis 
indicates conflicts between the dual roles of being the patient's advocate and the gate keeper 
(122). In summary, there exist only few studies on the physicians' role in the process of sick 
listing patients, and these are of varying quality (113), and the above referenced studies do not 
specifically address disability pension award.  
 
1.3.4 The push and the pull models for the transaction from work to 
disability pension  
Models explaining the transaction from work to disability pension award can be sorted into 
two groups: The push model focuses on involuntary processes beyond control of the 
individual forcing the employer out of work and on to disability pension. In opposition, the 
pull model is inspired by rational choice theory (123), and hypothesizes that the individual 
chooses disability pension over continued work having rationally considered issues as 
economic incentives for continued work versus disability pension over increased leisure time. 
Health is hardly a variable of interest in the pull model.  
Arguably the least complex model explaining causes for disability pension award is 
offered by Insurance Medicine. At the Faculty of Medicine in Oslo, Insurance Medicine is 
defined as the science of how diagnosis, treatment, and prevention of disease influence, and is 
influenced by insurance benefits based on medical criteria. It is also the trade of providing the 
diagnostic, therapeutic, prognostic, and etiological basis for decisions concerning insurance 
benefits (110). As follows from this definition, the inherent focus is on medically diagnosable 
disorders as causes for disability pension award. In Norway, variables on health according to 
this tradition are usually based on data from National Insurance Administration, and 
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tabulations are regularly published describing diagnostic distributions in disability pensions 
(Table 1). From 1998, all diagnoses for disability pension award were registered by ICD-10 
diagnoses. Muscle-skeletal disorders are the most common diagnosis in Norway (main 
diagnosis among 47.1% of all disability pensioners and 35.8% of new diagnoses), followed by 
mental disorders (28.0% of population and 21.5% among new awards) (30). This is in line 
with international studies (124, 125). Awards for mental disorders are prominent and 
increasing throughout the OECD countries (102, 106).  
 
Table 1. Diagnoses for disability pension in 2004  
 Per cent of new awards  
of disability pension  
Per cent of total population 
of disability pensioners  
Muscle-skeletal  35.8 39.1 
Mental  21.5 28.0 
Circulatory organs  10.2 4.2 
Cancer 5.6 2.8 
Injuries, poisoning, violence 3.7 3.7 
Nervous system  6.4 6.3 
Respiratory  3.1 2.5 
Temporarily lack of diagnosis  3.8 1.8 
Other diagnoses comprised1  9.9 11.6 
 1 Diagnoses each counting less than 3.0% of the population comprised  
 
 
Among the empirical studies, only few have used a prospective design to estimate the 
association between mental health and disability pension award, and they all confirm the 
strong impact of mental disorders (or symptoms of such) on disability pensioning (103, 104, 
126). A recent review identified five studies of associations between psychiatric disorders and 
sickness absence (125). Based on reimbursements, a US study fond a positive association 
between depression and sick-leave (127), and the same conclusion was reached in two 
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Swedish studies of women (128, 129). In contrary, no association between sickness absence 
and case-level depression was reported in the ECA project, but they did, however, find an 
effect of sub-threshold depression (37). Associations between any DSM-III-R and sickness 
absence was reported from the Netherlands Mental Health Survey and Incidence Study 
(NEMESIS) for men, but not for women (130). As previously noted, studies within this area 
are few, and the overall quality of most available studies is regarded as low (125).  
The Norwegian tradition in insurance medicine administration can be placed within 
the paradigm of the push model as the medical diagnoses and the impairment that follows is 
involuntary and forced upon the individual. There are several problems with this tradition, 
whereof some relate to issues of validity of the diagnoses reported in applications for 
disability pension. First, only ICD-10 diagnoses are accepted, and diagnoses relating to issues 
like alcoholism and obesity will usually not release disability pension award. There are, 
however, reports of independent effects of obesity on long-term sick-leave from Norwegian 
studies, even adjusted for physical and mental health (131). Second, despite being highly 
prevalent and commonly disabling, vague somatic symptoms without organic aetiology will 
only partly be covered by ICD-10, hence the discussion of functional disorders above (78, 89, 
91, 92). Third, both the physician and applicant (patient) might have preferences for certain 
diagnoses above others, e.g. for diagnoses with an assumed organic aetiology and somatic 
conditions rather than e.g. mental disorders. This might explain for example the popularity of 
chronic fatigue syndrome over depression, despite overlapping diagnostic criteria and 
effective treatment (90, 132). Physicians have most of their training within somatic medicine 
rather than in psychiatry, and will perhaps be biased in the direction of physical rather than 
mental diagnoses when multiple and vague symptoms are presented. It can be argued that the 
common physician will be more prone to conduct excess investigations to disconfirm 
potential grave diseases. Incentives in this direction may stem from litigations, and 
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availability of good routines for referrals, which are less developed within the common 
psychiatric conditions. Fourth, the tradition offers no explanation as to why it is common to 
continue work despite of mental and physical illnesses (labelled sickness presence) (133). 
Finally, there has been an increase in health-related insurance benefits in most OECD 
countries despite an overall improvement in most key indicators of health in the general 
population (134), which is more or less incompatible with explaining disability pensioning by 
medical diagnoses. In summary, medical diagnoses are at best only the last link in a causal 
chain leading up to disability pension award.  
One approach within occupational medicine has focused on work-place characteristics 
in prediction of morbidity employing the variables demand, control, and social support as 
descriptions of perception of the work situation (135). The combination of high demand and 
low control is reported to be associated with mental morbidity, whereas there is less support 
for a buffer-effect of social support on the work-place (136). Ongoing research is also 
indicating independent effects of this job demand-control-support model on long-term 
sickness absence (137). Support from colleagues and supervisors at work are reported to 
lower the risk of short spells of psychiatric sickness absence in studies based on the Whitehall 
II data (138, 139). The level of symptoms of mental disorders is varying across occupational 
groups (140), and farmers seem to be at particular risk (141). These models of causal 
mechanisms where workplace characteristics increase morbidity, which again increase the 
risk of disability pensioning, can be described as health related push factors.  
Push factors can also be related to economic structures in the society, for example 
factory closings (142) and downsizing (111). Economic push factors can be regarded as a 
consequence of the organization of labour in the society, where demands for profit, 
effectiveness, and ability for readjustments might exclude individuals from the labour marked. 
There is empirical support for the hypothesis that disability pension in such cases are used for 
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early retirement (143). This process of moving structural problems of the labour marked and 
society onto individuals is commonly known as a process of medicalization, as it then 
becomes a necessity for the expelled individual to obtain a medical diagnosis and demonstrate 
reduced ability to work to be awarded disability pension (144). It has been suggested that 
medicalization is politically necessary as large-scale unemployment is incompatible with 
social democracy (145). Whereas the term medicalization indicates a sick-role (144), there are 
also adverse effects of loss of job security on self reported health and minor psychiatric 
morbidity (146, 147). Mental illnesses may be particularly at risk for these processes as 
exclusion from the labour market is a risk factor for depression (148).  
Disability pensioning is more prevalent among lower socio-economic strata than 
higher (149, 150), but it is not evident from empirical studies whether the effects of social 
inequalities are mediated by health or other mechanisms. Social inequalities in health are as 
prominent in Norway as in other European countries, and have been fairly stable over time 
(151). Relative municipality deprivation seems to be associated with an higher incidence of 
disability pension award, and this effect contributes to marginalization of people living in less 
affluent areas out of employment and thus to widening socioeconomic inequalities in the 
population (152). Medical determinants alone cannot explain either the dramatic variations or 
the overall increased incidence rates of disability pension in the last two decades in Norway 
(153). Beyond socio-economic inequalities, disability pension award is also found to be 
positively associated with age, female gender and being single (100). 
Contrary to these involuntary push factors for disability pensioning are possible 
factors attracting individuals voluntary choose disability pension. Whereas most research 
under the push model is conducted within sociology and medical sciences, the pull model is 
more common in economy, which is illustrated by the famous quote by Duesenberry (1960): 
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"Economics is all about how people make choices; sociology is all about how people don't 
have any choice to make" (109).  
It is a conundrum how disability pensioning can increase in most OECD countries 
parallel to improvement in key health indicators (97, 134). As mentioned above, the pull 
model hypothesizes that the individual chooses disability pension over continued work having 
rationally considered issues as economic incentives for continued work versus disability 
pension over increased leisure (123). The theory is based on the presumptions of limited 
resources in a broad sense (which is uncontroversial). More problematic, though, is the 
presumption of rational behaviour in employees in competing companies aiming at 
maximising profit (123, 144). The pull model hypothesizes that individuals become disability 
pensioners as a result of rational economic assessment of available options (109), and the 
importance of health is presumed to be marginal. If the model is empirically valid, the 
obvious intervention would be to lower the potential income from disability pensions and 
sickness absence, and thus reducing the attractiveness of receiving support from these welfare 
systems. There is some empirical support for the pull model (109, 154), also from Norwegian 
studies (144, 155). For example, before 1978, the first day of a continued sickness absence 
spell was not covered. When this arrangement was changed in 1978, and also the first day off 
sick was fully covered, the rate of sick leave in men increased (156). In accordance with this 
finding, the opposite effect was found in Denmark in 1983 when their system was retrenched 
to the Norwegian system before 1978 (156).  
The pull-model has been criticized for not accounting for social inequality in health. 
Economic incentives can be defined as the ratio between the potential economic situation if 
on were to become a disability pensioner divided by the current economic situation. 
According to this definition low income groups will have a higher incentive for disability 
pension (144), but at the same time this is the group where health problems are more 
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prevalent (149, 151, 153, 157). It is therefore fair to postulate that health can be an obvious 
confounder in the association between economic incentives and disability pension award. 
Alas, information on this confounder is usually not available in studies examining these 
associations.   
Despite lack of empirical support, the pull model has had a major impact on policy 
making. For example, the level of compensation in short term sick leave was slightly reduced 
in Sweden with the aim of reducing the level of sick leave. A Norwegian Public Report 
recommended 20% reduction in wage compensation with the purpose of reducing the overall 
sick leave, and similar interventions were discussed also in relation to disability pension 
(156). These suggestions for interventions were never translated into policy changes, but they 
are based on the presumption that pull factors, economic incentives and rational choices have 
an impact on individual choices over continued work versus sick leave or disability pension.  
The recent review of research of causes (and consequences) of sickness absence and 
disability pensioning hardly covered research of effect of pull factors (98, 99). Addressing 
future need for research, the authors of the review briefly mentions a need for better scientific 
knowledge about how the design of the insurance system influences the prevalence of sick 
leave and disability pension. Further they state that in the public debate, the high level of 
sickness absence in some nations, such as Sweden and Norway, and particularly the recent 
strong increase, is explained as a result of changes in attitudes toward sickness absence, and 
they conclude that few scientific studies have targeted issues related to attitudes and the 
"absence culture" (101). This is, however, complicated as variables for economic incentives 
are difficult to operationalize as they rely on multiple factors and as health must be included 
as a confounding factor. On the contrary, any effect demonstrated of independent assessments 
of push factors, e.g. health problems are contrary to the pull model.   
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1.4 Mortality   
1.4.1 Registration  
Causes of death have in Norway since 1996 been classified according to the 10th revision of 
ICD-10. All deaths must be documented by a medical death certificate, usually "Death 
Certificate Issued by a Medical Practitioner / Report of Unnatural Death", alternatively 
"Report of Death by Local Policemen to Public Health Officer" (158). These certificates are 
sent to the Probate Court, which issues new death certificates that apply to the administrative 
and practical aspects of a death. This court will also provide a report of the death to the local 
population registry, which again forwards it to the Central Population Register. The Cause of 
Death Register is currently located at the Norwegian Institute of Public Health . All deceased 
persons who at the time of their death were registered by the Central Population Registry as 
living in Norway are included in the statistics, regardless of whether the death took place in 
Norway or abroad (158).  
The rate of autopsies has been falling in Norway to 12% in 1999 (159). The main 
purpose of autopsies is to determine the cause of death and to examine the precision of 
diagnoses that can be verified by post mortem autopsy. It has been objected that the current 
autopsy rate is too low and a potential threat to the quality in public health care (159, 160). 
Deaths that still lack a medical certificate when the statistics are prepared, and for which no 
other information is available, are registered with unknown cause of death (158). The rate of 
autopsies varies considerably between geographical regions within Norway (161) and 
Denmark (162) with higher rates in urban areas then in rural.  
 The most important source of error or biases as to the cause of death statistic is the 
clinical examination performed by the physician who is completing the death certificate. 
Further, the physicians report of the cause (or causes) of death employing a standardized form 
(158) is a source of error, as is also the process of classification, encoding and electronic 
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registration at the central administration (163). Classification of cause of death can be a 
complex matter when several causes of death are reported, multiple sequences are possible, 
and local cultural variations in encoding are in effect (163, 164). According to routines, the 
physician is contacted by the Cause of Death Register for additional information if further 
information is needed to establish the cause of death (158).  
Comparisons of mortality statistics between the Nordic countries have been difficult 
because of differences in empirical material, cultural differences, and differences in encoding, 
even though the same system of classification is employed (163).  
 
1.4.2 Concepts and classifications: Causes of death  
All deaths among inhabitants in Norway have since 1996 been encoded according to ICD-10. 
According to ICD-10, underlying cause of death is the disease or external cause of injury that, 
in the opinion of the physician, started the chain of events leading directly to death. In 
addition, up to six other contributory causes can be are registered. The underlying cause of 
death is defined as the disease or injury that initiated the chain of morbid events leading 
directly to death or the external circumstances of the accident or violence that was the cause 
of the fatal injury (158). According to ICD-10, the immediate cause of death is the injury or 
condition directly leading to death and which was caused by the underlying cause of death. 
Further, the term complication is used for any contributing causes of death which are not in a 
direct causal relation with the disease or condition that has caused the death (158, 165).  
The most important difference between the Norwegian cause of death statistics and the 
original ICD-10 (35) is that a fourth category for R99 (other poorly defined and unspecific 
causes of death), which in Norwegian mortality statistics is further described as R99.0 causes 
of death cannot be established, R99.8 cause of death not given (missing information), and 
R99.9 no information (the death is recorded in the central population register, but not reported 
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to the cause of death register). There are also some minor differences relating to hip fractions 
(W19), diseases of the nervous system (category for 'not classified elsewhere' G98), and road 
traffic accidents (moving versus stationary objects) (158).  
Behind the underlying cause of death registered in the Cause of Death Register is (for 
example myocardial infarction) there are obviously also a next level of causes (for example 
smoking). To be able to study causes of death beyond what is registered in the Cause of Death 
Registry, record linkages with other sources, e.g. journal registries from hospitals or national 
health surveys are necessary. This is – in Norway – made possible politically and technically 
through the national identification number system (163, 164).  
 
1.4.3 Mortality according to the Causes of Death Register  
The living age in Norway has been increasing linearly in both genders from the 1950s, and 
newborns in Norway in 2004 are expected to become 77.5 and 82.3 years (boys and girls, 
respectively) (166).  
On changes in cause-specific mortality, CVD mortality decreased from 49% to 39% of 
all mortality from 1979 till 2003, whereas cancer increased from 21% to 25% in the same 
period. Cancer is now the most prevalent cause of death in the population younger than 80. 
This is not due to an increase in cancer, but due to a reduction in CVD mortality. In the 
population under 80 years of age, cancer is now the most common cause of death (158, 166).  
 In year 2002, 5.4% of all deaths were due to external causes and not illnesses. The 
proportion of non-illness death is strongly associated with age; comprising 61% of deaths in 
age 15-24 dropping to 3.4% in 75 years and older. The absolute number of suicides is, 
however, relatively stable across age-groups from 15-24 and older (unsystematically varying 
between 11.8 and 17.1 of 100 000 inhabitants, the highest rate in the age-group 55-64). 
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Suicide is also generally more prevalent in men than in women (16.1 versus 5.8 respectively 
per 100 000 inhabitants in 2002) (166).  
 There appears to be a decline in the rate of suicides in Norway over the past two 
decades. In 1991 there was 675 suicides in Norway, which is 1.5% of all deaths that year 
(95% confidence interval 1.4 – 1.6). This compares to 494 suicides, 1.1% of all deaths, in year 
2002 (95% confidence interval 1.0 – 1.2). However, in the same period there have been an 
increase in number of deaths from mental diagnoses from 2.1% till 2.9% from 1990 till 2000 
(166). A death is encoded as suicide if intentionality for death is known, thus there is a burden 
of proof for the mortality diagnosis suicide, perhaps biasing the results in underestimating the 
rate of suicide.  
 In 2003, 469 (2.3%) men and 793 (3.6%) women were registered dead due to a mental 
disorder (ICD-10 code F00-F99). The majority of the mental disorders registered as causes of 
death were unspecified dementia (F03) (54% and 87% in men and women respectively) and 
other organic mental disorders (F00-F09) (6% and 5% in men and women respectively). In 
men, mental and behavioural disorders due to psychoactive substance use accounts for 36% of 
mortality for mental disorders, comparing to 5% in women. Affective disorders (F30-F39) 
were registered as cause of death in 26 deaths, which accounts for 2% of mortality for mental 
disorders and 0.06% of all mortality in 2003. One man was registered dead due to anxiety 
disorders (F40-F48, Neurotic, stress-related and somatoform disorders), while five women 
died from anorexia nervosa (F50) (166). In summary, mental disorders account for very little 
of the total mortality according to underlying causes of death in the mortality registry. Any 
effect of anxiety or depression can be suspected to be within suicides, accounting for 
approximately 1.1% of all deaths, but suicide obviously has causes beyond anxiety and 
depression and also beyond mental disorders. Mortality due to mental disorders (F00-F99) is 
mainly registered as dementia, and in men, also behavioural disorders due to psychoactive 
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substance use. According to the Causes of Death Register, mental disorders in general, and 
anxiety and depression in particular, have limited impact on mortality.  
 
1.4.4 Anxiety, depression and mortality  
Depression is in the literature reported to be a risk factor for mortality beyond what is 
described as underlying causes of death in the Causes of Death Register (158). The picture is 
somewhat more unclear as to the effect of anxiety. The following six issues are discussed:  
 The first question concern whether there is an effect of depression on general 
mortality. There is broad evidence that depression increases general mortality, both from large 
scale studies and reviews (167-172), but residual confounding cannot be excluded (169). The 
effect of psychological distress (as measured with the 30-item General Health Questionnaire 
(GHQ)) on mortality was explained by adjustment for baseline physical illness in large 
prospective community study, and the authors suggested that psychological distress is a 
reflection of baseline physical illness that increases mortality, consequently placing 
psychological distress on the causal pathway between physical illness and mortality (173). 
Baseline physical illness is obviously also a relevant confounder in the association between 
depression and coronary heart disease (174), but there is evidence suggesting an independent 
effect (23, 174, 175). This is a relevant objection as depression is increased in individuals 
with physical conditions of many kinds including e.g. cancer (176, 177), CVD (20), diabetes 
(178) (though questioned as to confounding from comorbid conditions and complaints (74, 
75)) and stroke (179).  
The second question addresses if severity of depression relate to general mortality. 
This question is difficult to address by comparing studies that has used different instruments, 
possibly with non-comparative cut-offs for depression, but there is some evidence for higher 
mortality in psychotic depression than in severe non-psychotic depression (180). An extensive 
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review of the literature suggests almost equal effects of major depression and sub-clinical 
forms of depression (172). It remains unclear if severity of depression relate to mortality.  
The third question relates to what mechanisms may be involved in the effect of 
depression on mortality. A whole range of mechanisms are proposed, but evidence is 
generally weak (181). The propositions can be presented as two main mechanisms (182): The 
first relates to lifestyle, namely that depression may be a distal risk factor related to a number 
of proximal risk factors that increase morbidity and mortality from CVD and other diseases. 
Candidate agents in this mechanism (182-184) comprise smoking (185, 186), lack of exercise 
(187), non-adherence to treatment strategies (188), and increased alcohol consumption (189). 
The second group of proposed mechanisms relates to biological change occurring in 
depression (182), e.g. increased cortisol (190), increased platelet coagulability (191) and 
changes in heart rate variability (192, 193). A review of possible mechanisms underlying the 
effect of depression on CVD mortality (comprising both lifestyle factors and biological 
change occurring in depression) suggested seven candidate mechanisms including 
antidepressant cardiotoxicity, associations between depression and cardiac risk factors (such 
as cigarette smoking, hypertension, diabetes and reduced functional capacity), association 
between depression and greater coronary disease severity, nonadherence to cardiac prevention 
and treatment regimens, lower heart rate variability (HRV) reflecting altered cardiac 
autonomic tone, increased platelet aggregation, and inflammatory processes (191). The 
authors of this review concluded that they were “struck by the many plausible ways in which 
depression could have a negative effect on cardiac functioning and coronary disease”. They 
were, however, unable to indicate which, if any, of the suggested mechanisms that is 
empirically relevant.  
 The fourth question concerns which mortality diagnoses depression are associated 
with. Most of the literature on depression in relation to cause specific mortality concerns CVD 
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mortality (21-23, 179, 182, 194-197). As mentioned above, there are multiple candidate 
mechanisms proposed for the effect of depression on CVD mortality (191). Suicide is an 
obvious mortality diagnosis related to depression (184), but as suicide is a rare event in the 
general population (198), it is unlikely to account for all of the effect of depression on 
mortality. The risk of suicide has long been overestimated in depression (181). A recent meta-
analysis of 47 studies estimated that the lifetime risk of suicide ranges from 2.2% to 8.6% in 
patients with depression (199), which compares to less than 0.5% in individuals without 
depression (181). As suicide is a rare event, suicide accounts for very little of the effect of 
depression on mortality. Follow-up studies of depressed individuals found very few suicides 
among deaths during follow-up (170, 198). There might, however, be hidden suicides among 
other mortality diagnoses (181). Also unnatural deaths beyond suicide have been reported to 
be associated with depression (25, 200). The evidence for effects of depression on mortality is 
weaker for causes of death beyond CVD mortality and suicide (200). From the existing 
literature, it is unclear whether the effect of depression varies across mortality diagnoses.  
 The fifth question concerns hypothesized effect moderation of gender: The effect of 
depression on mortality is reported to be stronger in men than in women (170, 201, 202), but 
as these findings are reported with reference to stratified analyses within each gender rather 
than by demonstration of an interaction between gender and depression in prediction of 
mortality, the validity of these findings have been questioned (169). It is also unclear if gender 
moderates the effect of depression on mortality.  
 The sixth question concerns the role of comorbid anxiety with regard to the 
association between depression and mortality. This question is relevant for at least two 
reasons: Anxiety and depression commonly occur comorbid (50), and comorbid anxiety 
depression is associated with higher levels of impairment (107), more physical diseases (57) 
and more help-seeking (45) than anxiety or depression alone. However, compared to the 
 51
literature on mortality, there are very few publications on the association between anxiety and 
mortality, and also comorbid anxiety depression. In the few reports available the results are 
conflicting, with reports of both positive (203) and negative (204) associations. The latter 
study is probably the best available examining the association between anxiety and mortality; 
it was satisfactory powered (N=5 057 patients referred for routine exercise testing for chronic 
coronary artery disease) and employed the HADS (204). However, comorbidity between 
anxiety and depression was not examined. Anxiety is also reported not to be associated with 
mortality (205, 206), but these studies are small and possibly under-powered.  
 There are numerous clinical and epidemiological studies of hypothesized effects of 
depression on mortality, originating from many different countries. The majority of studies 
follow up clinical samples, e.g. patients hospitalized for CVD after they have screened them 
for depression. Residual confounding is likely to be a problem in the literature due to lack of 
access to information in many of these studies (169). The focus on mechanisms underlying 
the effect of depression on CVD mortality, and the strong focus on CVD mortality rather than 
other diagnoses is perhaps unjustified as the evidence for depression being a stronger risk 
factor for CVD mortality than other mortality is weak.  
 
1.5 Aim of the study  
Employing a unique record-linkage between a large health-survey of the general population 
and the national registries on disability pension and mortality, the aim of the present thesis is 
to address questions concerning effects of anxiety and depression on work-related disability, 
general mortality and cause specific mortality.  
In the first paper, the specific objectives were to examine if anxiety and depression 
were independent predictors, adjusted for physical health, both of disability pensions for all 
causes, and in particular for pensions officially awarded for physical conditions. In order to 
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examine other factors relevant to the push- and the pull models, we expanded the model 
beyond physical and mental health to also examine the effects of socio-demographic and 
behavioural variables on disability pension award.  
The second paper concerned general mortality, and the specific objectives were (a) to 
examine effects of case-level anxiety and depression as well as comorbid anxiety and 
depression upon mortality, (b) to clarify the shape of the association between mortality and 
symptom load of anxiety and depression, (c) to investigate possible mediating and 
confounding factors in these associations, and (d) to test the hypothesis that depression is a 
stronger risk-factor for mortality in men than in women.  
 The third paper addressed issues concerning cause-specific mortality in relation to 
anxiety and depression. Specific objectives were to (a) compare the strengths of the 
associations between anxiety/depression and mortality across causes of death, (b) to compare 
confounding and mediating factors in CVD with other causes of death comprised. The 
analysis also addressed issues on hypothesized hidden suicides in non-illness deaths beyond 
suicides.  
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2 Material and methods  
2.1 Material  
The three present studies all employ historical cohort designs. Baseline information on mental 
health and confounding factors was obtained from the HUNT-2 study (207). Outcomes of 
mortality and disability pension award were identified in public registries, and merged with 
the HUNT-2 study employing 11-digit personal identification numbers.  
 
2.1.1 The Health Study of Nord-Trøndelag County (HUNT)   
The first Health Study of Nord-Trøndelag County in 1984-86 (HUNT-1) aimed at screening 
the entire population of Nord-Trøndelag County age 20 and older for hypertension, diabetes, 
lung diseases and quality of life. Each participant was asked to complete two questionnaires, 
and a physical examination with measurements of BMI, chest x-ray screenings, and non-
fasting blood glucose. Approximately 40 publications were based on the first HUNT survey 
by 2003 (207).  
The second HUNT study (HUNT-2) was carried out from August 15th 1995 till June 
18th 1997, and is the main source of data for the present studies. The number of main 
objectives in the HUNT 2 study was expanded from the first survey with projects on 
cardiovascular disease, diabetes, obstructive lung disease, osteoporosis and mental health, in 
concordance with contemporary priorities of the health authorities (207). The second HUNT 
study is perhaps the most comprehensive health survey available, with its broad coverage of 
physical conditions, mental health, and somatic symptoms, and the cohort that participated in 
both the first and the second data wave are acclaimed as valuable for studies where two-wave 
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panel data are needed. Inclusion of mental health in the second HUNT study was perhaps the 
most radical change from the traditional focus on somatic conditions in Norwegian health 
screenings (208). HADS was found suitable as a screening instrument for mental health as it 
does not give a floor effect when employed in the general population, it does not included 
items on suicidal ideation or psychotic thoughts that may be provocative or offensive, and it 
had previously been applied in several studies within psychiatry and somatic medicine (209). 
The HUNT-2 data without record linkages have been utilized by research groups in Nord-
Trøndelag (208) and Bergen (210). 
 The population in Nord-Trøndelag County counted 127 000 residents in 1995-97, and 
is fairly stable with a net migration of 0.3% per year (1996-2000). The population is also 
homogenous with less than 3% non-Caucasians (207), which obviously represent a limitation 
with regard to the generalization of findings. The information collection was performed in 
multiple steps: First, an invitation letter for participation in the study was sent by mail with an 
attachment of a three-page questionnaire (labelled questionnaire 1) and with an information 
folder. Questionnaire 2 was distributed at the clinical examination, which included 
measurements of blood pressure and heart rate, height and weight, waist and hip 
circumference. In summary, the available data from the HUNT study cover subjective health, 
diabetes, lung diseases, cardiovascular diseases, thyroid diseases, muscle- and skeletal 
diseases, mental diseases (especially anxiety and depression), quality of life measures, 
migraine and other headaches, and physical and mental dysfunction, prostate complaints, 
urine incontinence, and female reproductive data i.e. on menarche, pregnancies, hormone use, 
and gynaecological diseases. Information on personal environment includes residence, size of 
household, education, occupation, in-house environment, neighbourhood characteristics, 
friendships, and sense of humour. Information on personal habits included food intake, use of 
drugs, use of alcohol and tobacco, and physical activities. Some items covered family medical 
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histories and use of health services. Additional questionnaires were used in sub-samples, i.e. 
questionnaires on lung diseases, diabetes, hypertension, hearing disorders, and vision. Some 
selected groups were invited to a more detailed (phase 2) examination, i.e. participants in 
studies on diabetes, prostate, headache, lung function and bone density (207). 
 Participants in need of further medical attention, e.g. individuals with high blood 
pressure (diastolic blood pressure above 125 mmHg), elevated non-fasting blood glucose 
reading (>11.1 mmol/l) (207), or elevated scores on the total HADS sum-score (>25 points on 
the total HADS scale, and a random sample of individuals with scores slightly below this cut-
off) (208) were informed in writing and advised to see their general practitioner for further 
clinical tests and possible treatment.  
 A total of 94 194 individuals aged 20 years and older were invited to the HUNT 2 
study. As many as 1258 died or moved before attending the study, resulting in a total 
population of 92 936 eligible for participation. A total number of 66 140 participated in some 
parts of the study (71.2%). The participation rate was higher among women than men, and 
lowest among 20-29 year olds (207). The low level of participation among the youngest ones 
was in large part caused by difficulties in obtaining directories of residency in these age 
cohorts due to studies, military services, long vacations, and temporary jobs in other counties 
or abroad. Out of 92 100 individuals aged 20-89 years at the time of the survey, 62 344 filled 
in valid ratings on HADS (67.7%) (77), and 60 869 (66.1%) individuals also had valid 
responses on a broad range of somatic and social variables (76).  
 Shortly after the termination of the data collection in HUNT-2, a 2.5% random sample 
of non-attendees (n=685) were approached for a study with the purpose of determining 
reasons for non-participation (211). Approaching non-participants both by mail and telephone 
resulted in a total sample of 326 individuals (47.6%). In individuals within working age, the 
main reasons for not attending the study was lack of time, emigration from the county, being 
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busy at work, that they had forgotten, or no reason at all. Among the age group of 70 and 
older, many reported regular follow-ups by physicians or at the hospital, and therefore did not 
see any need to attend. Some individuals (10%) could not attend because they were 
immobilized due to disease, and some (4%) refused due to long waiting time at the screening 
site. Rather few (9%) reported that the survey was unnecessary or simply that they were 
unwilling to participate (207, 211). Previous studies have indicated more mental health 
problems in non-participants in the context of health surveys (212). This was not examined in 
the HUNT non-participation study (207, 211), but is most probably relevant for the HUNT 
study as well.  
 
2.1.2 National registries of work-related disability  
Information on award of disability pension was available from registries of the National 
Insurance Administration. These contain information on date of award, proportion of 
disability (50-100% disabled), and up to two diagnoses warranting disability pension for each 
application. Multiple applications are common due to changes in diagnostics and degree, as 
many initially are awarded a partial disability pension. Accumulated, across the disability 
pension population, most individuals are recipients of 100% disability pension. Diagnoses in 
these registries were up until 1998 encoded according to ICD-9, but from then on in ICD-10 
categories (30). Data from the HUNT study were linked to the disability registry by 
employing a personal identification number. Individuals awarded disability pension before 
participating in the HUNT or in a quarantine period between the HUNT study and start of the 
follow up period could be identified (with the purpose of exclusion from the study).  
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2.1.3 The Norwegian Causes of Death Register  
The Norwegian Cause of Death Register (158, 164, 166) is presented above (chapter 1.4.1 and 
1.4.3). Mortality data were linked to the HUNT database applying the 11-digit national 
personal identification number (207). The mortality data covered a follow-up period from 
attendance in the HUNT study (August 1995 till June 1997) till the end of year 2000. Mean 
follow-up period was 4.4 years (SD 0.68). Mortality statistics were also available for non-
attendees to the HUNT study. 
 
2.2 Exposure: Anxiety and depression  
Anxiety and depression are the exposure measures in all three papers, and are measured 
employing the HADS.  
Diagnostics within the field of psychiatry is often criticized by other medical 
specialities for being vague or woolly, commonly with reference to lack of biological markers 
of pathology (213). Consequently, psychiatry was among the first medical disciplines to 
develop internationally recognized operationalized diagnostic criteria with corresponding 
standardized approaches to distilling symptoms into diagnoses or scalable traits. These 
criticisms are therefore today largely misplaced, as the measures applied in the field of 
psychiatric epidemiology now is perhaps more valid and reliable than even for some 
biological measures (213).  
 
2.2.1 Scale properties of HADS  
HADS is used for measuring anxiety and depression in all papers, and is a self-report 
questionnaire comprising 14 four-point Likert-scaled items, seven for anxiety (HADS-A) and 
 58 
seven for depression (HADS-D). To avoid false positive cases in contexts of somatic illness, 
no somatic items or items regarding sleeping difficulties are included (49).  
However, even though information is based on self-report, it is not correct to claim 
that participants report having anxiety or depression, as the report merely are symptoms 
recognized as core features of these disorders. It is obviously – and possibly also likely – that 
many individuals report symptom loads above cut-off without agreeing they have anxiety or 
depression. Items are reported in table 2.  
 
Table 2. HADS items  
Scale / item # Text  
A / 1 I feel tense or wound up 
A / 3  I get a sort of frightened feeling as if something awful is about to happen 
A / 5 Worrying thoughts go through my mind  
A / 7 I can sit at ease and feel relaxed 
A / 9 I get a sort of frightened feeling like ’butterflies’ in the stomach  
A / 11  I feel restless as if I have to be on the move  
A / 13 I get sudden feelings of panic  
D / 2 I still enjoy the things I used to enjoy  
D / 4 I can laugh and see the funny side of things  
D / 6 I feel cheerful  
D / 8 I feel as if I am slowed down  
D / 10 I have lost interest in my appearance  
D / 12 I look forward with enjoyment to things  
D / 14 I can enjoy a good book or TV programme   
Questions are answered on a four-point scale from 0 to 3, labels varying between items.   
Items 2, 4, 6, 7, 12 and 14 are reversed before summation.  
 
 
As described above (chapter 1.1.4), HADS-A and D share 30% of the total variance in 
symptoms of anxiety and depression (50). Despite this strong correlation between the two 
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sub-scales, Principal Component Analysis extracted two factors according to the originally 
proposed model (49) in the HADS that accounted for 57% of the variance. The two-factor 
solution was found in the total HUNT sample, in sub-samples defined by clinical (both mental 
and physical) characteristics, and in sub-groups defined by age and gender. The internal 
consistency, as measured with the Cronbach's Coefficient Alpha, was good with values of 
0.80 and 0.76 in the anxiety and depression scales respectively. The homogeneity of the scales 
was also good, as anxiety items loaded more on anxiety factors than on the depression factor, 
and vice versa for depression. This consistent pattern was found both in the total sample and 
in the sub-samples. However, items 6 ('I feel cheerful') and 7 ('I can sit at ease and feel 
relaxed') diverged to some extent from this pattern by loading substantially on both factors 
(50).  
 
2.2.2 Case-finding abilities of the HADS  
The LEAD-principle for diagnosing mental disorders (214) is perhaps still the gold standard 
within psychiatry (215). LEAD is an abbreviation for longitudinal observations made by 
clinical experts who have all relevant data for deciding on a diagnosis. The issue of whether 
the clinical expert is necessary for defining cases with mental disorders is a continuously 
ongoing debate between epidemiologists and clinicians.  
Obviously, self-report instruments like HADS do not subscribe to the LEAD-principle. 
Employing self-administered screening instruments will limit the assessment of symptoms to 
what the patient is able to report. A commonly employed screening instrument for depression 
in primary care is the Montgomery-Åsberg Depression Rating Scale (MADRS) (216), which 
includes one item on external symptoms of sadness which is not based on self-report. The 
other nine items are based on self-report, though reported through the physician. Many 
physicians have, however, known their patients over a long period of time, and rely on their 
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clinical impression rather than structured interviews. The Clinical Global Impression – 
Severity (CGI-S) is a standardized dimensional one-item assessment tool that is based on the 
clinician’s judgement of severity of generalized anxiety disorder (GAD) and major depressive 
disorder (MDD) (217), which corresponds to clinical assessments solely based on the 
clinician’s general judgement. The CGI-S approach is perhaps more in line with the LEAD-
principle for diagnosing mental disorders than screening instruments like HADS.  
Which of the two approaches is most reliable is also an empirical question that has 
been examined in a recent Norwegian publication (218), where the more comprehensive 
instruments Generalized Anxiety Questionnaire (GAS-Q) (219, 220) and the Depression 
Screening Questionnaire (DSQ) (221, 222) were used as gold standards for  DSM-IV 
diagnoses of GAD and major depressive episode (MDE) respectively. Employing both HADS 
and CGI-S as continuous measures and GAS-Q and DSQ as dichotomies for DSM-IV 
diagnoses (and gold standards), the self-rating approach (employing HADS) was a better 
case-finder for both GAD and MDE than the clinical assessment approach (CGI-S). The area 
under the curves (AUCs) in receiver operator curves (ROCs) were 0.88 and 0.77 for self-
rating and clinical assessment respectively in GAD, and 0.93 and 0.87 respectively in MDE 
(218). The context of this analysis was a pharmaceutical study for examining hypothesized 
effects of serotonin noradrenalin reuptake inhibitors on anxiety disorders. General 
practitioners agreeing to participate in the study could be presumed to be interested in mental 
disorders, and the study itself might also increase their attention to mental disorders. 
Consequently, the study is possibly biased in favour of the clinical assessments rather than 
HADS. In conclusion, even though HADS is far from the LEAD-principle, it is a better case-
finder than brief clinical assessments performed by general practitioners.  
According to a literature review covering 31 studies, HADS has shown good case-
finding properties for anxiety and depression in patient populations in primary care as well as 
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in hospital settings (56). A cut-off score of 8 on both subscales was found to give an optimal 
balance between sensitivity and specificity, both at about 0.80, for depression and anxiety 
according to DSM-III and IV, ICD-8 and 9. This is similar to the sensitivity and specificity of 
other screening instruments, e.g. the GHQ.  
 
2.2.3 Operationalization of anxiety and depression employing HADS  
HADS was operationalized in five ways in the present study:  
 For most purposes, anxiety and depression were used as categorical variables with 
case-level for scores of 8 and higher. This is in line with multiple publications using HADS 
both internationally (56) and in Norway (e.g. 73, 80, 223). Some variance in HADS is lost by 
this approach, and false negative cases will be prevalent employing cut-off levels at this 
range. Misclassification at random due to e.g. measurement error is likely to occur, in 
particular in individuals with scores near the immediate range around the cut-off (41), 
resulting in underestimation of true effect sizes. However, this operationalization is in 
accordance with the tradition in the relevant journals, and eases communication of results in 
milieus familiar to categorical measures rather than continuous ones.  
 A second categorical approach dealing also with comorbidity was categorization of 
four groups by the HADS: No case-level anxiety or depression (range 0-7 on both scales), 
case-level anxiety or depression, or comorbid anxiety depression (range 8-21 on both scales). 
This approach is also in accordance with multiple publications employing HADS in the 
HUNT study in Norway (e.g. 71, 224), but is not as widely applied as the categorical 
approach for analyses involving each scale separately. The advantage of this approach is the 
possibility of examining issues relating to comorbidity between anxiety and depression, e.g. in 
associations with work-related disability and mortality. Limitations are as for categorical 
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measures in general, which will be discussed in more detail in chapter 4.3.2 under residual 
confounding.  
 The third approach was to employ anxiety and depression as continuous variables 
(range 0-21 points on each sub-scale). The main advantage in this approach is less loss of 
variance, but is disadvantaged as it presumes comparable steps along the entire scale, e.g. that 
the clinically relevant difference between scores 0 and 2 compare to that between 7 and 9, and 
15 and 17. This approach is widely used in publications where HADS is used (e.g. 77). 
Quadratic terms of these continuous measures were applied to examine U-shaped 
associations.  
A fourth approach was to operationalize anxiety and depression according to quartiles 
in the distribution, and to include the variables as categorical measures in regression models. 
This approach combines advantages and disadvantages to continuous and dichotomous 
approaches, but with the special advantage that the approach is suitable for examining 
associations also with other shapes than linear and U-shape across the entire distribution. This 
approach has, to the best of my knowledge, not been applied to HADS previously, but is 
common in epidemiologic research.   
Finally, the last approach is also a categorical one, with groups for severity of anxiety 
and depression according to the originally proposed model (49): No disorder [range 0-7], mild 
disorder [8-10], moderate disorder [11-14], and severe disorder [15-21]. This approach is not 
commonly applied, and the validity of cut-offs and labels are questionable. The approach has, 
however, advantages for examining dose-response associations between severity and an 
outcome within the clinical range of the scale.  
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2.3 Outcome  
2.3.1 Disability pension award  
Award of disability pension is the outcome variable in the first study. This measure is 
extracted from administrative registries (30, 225).  
 As a measure of work-related disability in general, the validity of disability pension 
award might be questionable. National policies for regulating health related benefits vary, but 
essentially all adhere to the medical model for awarding disability pension, where physicians 
are appointed to a gate-keeping function with the purpose of restricting disability pensions to 
individuals with work-related impairment from a diagnosed medical condition (134).  
There is, however, several issues questioning the validity of disability pension award 
for the construct of work-related disability: The first relates to causes for disability pension 
award beyond health, including both push- (142, 149-151, 153, 226) and pull-factors (123, 
156, 227) as described in chapter 1.3.4. There are reports of fairly good self-rated health 
among disability pensioners (134, 228), and improvement in public health indicators over the 
last decades have taken place in parallel to an increasing number of people living on health 
related benefit schemes (126, 134).  
The second relates to the roles of physicians with regard to sick-listing practices 
(discussed in chapter 1.3.3); issues relating to conflicting roles between gate-keeping in terms 
of principal agent theory (123) and being the patient's advocate (119, 122). As described 
above, physicians rarely restrict long-term sick-leave in patients requesting such benefits 
(113-115). Subjective perceived health is reported to be a strong predictor of disability 
pension award (229), and the effect of perceived health on disability pension award can hardly 
be attributed to objective indicators of health (230, 231).  
The third issue relates to possible under-utilization of disability pension award in 
individuals with actual work-related disabilities. Individuals on unemployment benefits are 
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reported to suffer from more health problems than employed individuals (148). Work-related 
disability might also in some cases be supported financially within the family, thus not subject 
themselves to disability pension.  
 All these factors are reducing the validity of disability pension award as a measure of 
work-related disability, thus weakening possible effects of mental health on disability pension 
award.  
 
2.3.2 General mortality and cause specific mortality  
General mortality is the outcome variable in the second study, and the information obtained 
from relevant registries is regarded highly reliable, and the only source of drop-out is 
emigration from Norway.   
 More questionable, though, is the reliability in cause specific mortality, which relies 
on diagnosis for underlying cause of death, which is the outcome variable in the third paper. 
Issues relating to reliability problems in the registration process are described in chapter 1.4.2 
and 1.4.3. The problem of deciding on the level in the causal chain leading up to mortality is 
also an issue (chapter 1.4.4).  
 
2.4 Mediating and confounding variables    
A whole range of factors are associated with both mental disorders, disability pension award, 
and mortality, including physical conditions, somatic symptoms, biological factors (BMI, 
blood pressure, cholesterol level), socio-demographic factors, and health related behaviour. 
These will be described in more detail here.  
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2.4.1 Somatic conditions 
Somatic conditions are in HUNT measured by self-report. Questions relating to 
conditions popularly self-diagnosed are framed in the way have a physician ever told you that 
you have [e.g. osteoporosis]. Copies of questionnaires are available in Norwegian (232). Data 
on physical conditions were collected by two questionnaires, one to be completed before the 
physical health examination, the other to be completed after the examination and returned by 
mail (207).   
An index for self-reported somatic diagnoses comprised asthma, angina pectoris, 
stroke, myocardial infarction, diabetes, goitre, hypo- and hyper-thyroid function, other 
diseases in thyroid gland, fibromyalgia, osteoporosis, arthritis, rheumatism, ankylosing 
spondylitis, myocardial infarction, cancer, epilepsy, blood-pressure (being treated or 
monitored), and one open item for any other illness.  
Obviously, the above mentioned conditions are not all equally relevant for the 
outcomes of interest. Consequently, the single items comprising the index was weighted for 
medical doctor (MD) certified sick-leave in the paper predicting disability pension award, and 
for mortality in the mortality papers before summarized as an index. Technical details are 
described under statistics (chapter 2.6.6).  
Self-report of physical diagnoses implies a problem of reliability, which perhaps have 
received less attention than measures of mental health by self-report (213). In a separate 
study, we examined the concordance between self-report of cancer (present or former 
diagnosis) and registrations in the Cancer Registry of Norway (CRN) (233). Excluding basal 
cell epithelioma, 20% of former (and current) cancer patients did not self-report their 
diagnosis in correspondence with information from the registry. The deviating cases were 
more often men, smokers, and had their cancer diagnosis as very young or as elderly. In 
reverse, among 63347 HUNT-2 participants without any record of cancer according to CRN, 
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479 individuals (1%) still claimed a cancer diagnosis, resulting in 20% false positive cases of 
self-reported cancer. As there are no national complete registries of other diagnoses, we have 
not been able to examine the accuracy of self-report of other somatic conditions. As reported 
by Prince and colleagues (213), also among the many HUNT-2 study there is less attention to 
problems of reliability in self-report of somatic conditions then psychiatric conditions, and the 
publication on self-report of cancer (233) have received surprisingly little attention.  
The consequences for reliability in self-report measures of somatic conditions for the 
present studies relates to residual confounding, which will be further discussed in chapter 
2.6.2.  
 
2.4.2 Somatic symptoms  
As for somatic conditions, an index for somatic symptoms was included as a confounding 
factor in all three papers. It is computed from reported somatic symptoms and then counting 
the number of organ systems these symptoms stem from. These were weighted as described 
for somatic conditions (chapter 2.4.1, statistical procedure described in chapter 2.6.6). Items 
in HUNT-2 on somatic symptoms without a hypothesized organic aetiology (e.g. neck pain, 
but not whiplash injury) were regarded as a somatic symptom.  
The organ systems comprised gastrointestinal symptoms (four questions on nausea, 
heartburn, diarrhoea and constipation), musculoskeletal symptoms (pain in neck, shoulders, 
elbow, hands, breast, back (three areas), hips, knees, and ankles), head (two questions on 
headache and migraine), senses (two questions on hearing and sight), heart (one question on 
palpitations) and respiratory function (one on respiratory problems).  
The approach of counting organ systems wherefrom symptoms were reported (rather 
than counting single symptoms) was inspired by criterion D in the ICD-10 diagnosis for 
somatization disorder (ICD-10 code F45.0) (35). Again inspired by somatization disorder 
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(criterion A), empirical examination of confounding effects of somatic symptoms was always 
performed also adjusting for somatic conditions; this to exclude overestimating the 
confounding effects of somatic symptoms that could be secondary to any diagnosed physical 
condition. Criterion B and C could not be included in the operationalization of the index, and 
even though the index likely will measure the tendency to somatise, it should not be regarded 
as a proxy for F45 Somatization disorder.  
 
2.4.3 Biological measures  
Physical measures of body mass index (BMI), systolic and diastolic blood pressure, and non-
fasting total cholesterol were obtained by a specially trained nurse during the screening, and 
all these variables were encoded in quartiles and regarded as relevant confounders in the 
mortality papers. Based on available information on risk-factors for disability pension award 
(98, 101, 105, 110), these variables were not regarded be relevant in the analysis of disability 
pension award.  
 
2.4.4 Self-rated impairment  
Physical impairment was based on four questions on self-evaluated moderate or severe 
impairments from somatic disease, reduced locomotivity, hearing and sight, added to one 
index from 0 (no impairment) – 4 (impairments from all four). This index was used in the 
mortality papers, but to avoid circularity, not in the paper predicting disability. Previous 
analyses employing this index have shown that it is closely related to mental health and age 
(76), and inclusion of this factor as a confounder probably leads to statistical over-adjustment.  
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2.4.5 Socio-demographic factors and health related behaviour  
Health related behaviours were included as confounding factors in the mortality paper, and 
also in a parsimonious model predicting disability pension award. Variables included current 
smoking habits, physical activity, and alcohol consumption (as measured by CAGE (234)). 
The two latter variables were obtained from a second questionnaire with about 20% lower 
response rate; missing responses were encoded as a separate category.  
 Educational level was encoded according to the highest completed educational level 
on a three-point ordinal scale from compulsory school only to university level (45). An index 
for socioeconomic status according to the Erikson Goldthorpe Portocareros was computed 
(157).  
 
2.5 Research strategy: Historical cohort designs  
Research methods in psychiatric epidemiology have developed in several stages; Suicide by 
Durkheim in 1897 perhaps being a starting point. In the 1930s to the 1960s, non-standardized 
clinical diagnoses were employed in psychiatry, and the few population-based studies in this 
period (235) relied on the assumption that common clinical training for psychiatrists would in 
some way ensure reliability and validity of their diagnostic assessment (96). The second phase 
of methodological development led up to standardization of assessments e.g. as in the US 
Stirling County Study (236), which used self-report instruments with psychopathology scaled 
on a continuum from health to disease. This was certainly no blind alley in the history of 
psychiatric epidemiology (96). The development diagnostic manuals leading up to today's 
DSM-IV (34) and ICD-10 (35) marked the third phase of the development of methods in 
psychiatric epidemiology (96). Whereas observational research relates to describing what 
there is, analytical research concerns issues of why (237). The early population based studies 
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like ECA (2) can, however, be criticised for gathering relatively little information beyond 
prevalences stratified by socio-demographic factors. Prince et. al. quotes findings of 
associations between economic deprivation and common mental disorders (238), and also 
depression and child abuse (239, 240), as examples of more theory driven research of 
aetiologies based on the NCS (96), but they argue that the real development has been in the 
use and increasing sophistication of analytical designs, including both case-control designs 
and cohort studies. They emphasize among others Patel et. al.'s findings of effects of mothers' 
mental health on infectious disease and development in offspring (28, 241) as examples of 
these more advanced research strategies in psychiatric epidemiology (96).  
 There are three kinds of cohort studies (242): Classical cohort studies select groups on 
the basis of exposure, and follow them in order to compare incidences of outcomes of interest. 
Population based cohort studies usually select the panel on the basis of convenience, and 
multiple exposures are ascertained at baseline and related to multiple outcomes of interest 
over a follow-up period. The historical cohort study is a retrospective variant of the 
population based cohort design in that exposures of interest are measured years before the 
commencement of the study, typically for other purposes. Outcomes are typically identified in 
other sources and traced back to baseline. Essential features of cohort studies are that 
participants are defined by their exposure status rather than by outcome (as in case-control 
design), and that it is longitudinal with measurements of exposure before outcome. Weich et. 
al. (242) describe the famous Barker study of effects of being small for gestational age (SGA) 
on midlife vascular and endocrine disorders (243) as examples employing a historical cohort 
design, a research design also applied in a record linkage between the Medical Birth Registry 
and the HUNT study in examination of effects of SGA on mental disorders in early adult life 
(244).  
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 The present three studies are probably best described as historical cohort designs, as 
associations between mental health and work-related disability and mortality were 
hypothesized after the health survey. However, the project of linking HADS and the mortality 
registry was described prior to HUNT-2 as regards hypothesized effects of the intervention 
study on suicide prevention (208), and several somatic HUNT-2 projects were aiming at 
cohort designs with mortality and disability as endpoints (207), thereby providing informed 
consents and necessary approvals for the present studies.  
 There are advantages and disadvantages to historical cohort designs (242), and many 
are relevant for the present studies: Advantages include minimal observer- and subject bias 
(as registration of outcome is blind to exposure status), as the specific hypotheses of interest 
were not known for the participants, and even not formulated at the time of the health 
screening. The longitudinal design with exclusion of individuals where the outcome of 
interest is manifest prior to the health survey (obviously mortality, but also disability pension 
award),  renders it possible to study the temporal sequence between outcome and exposure.  
Prospective cohort designs are indeed very costly and time consuming, but current 
Norwegian research policy allow us to link data sources like the HUNT study and public 
registries. This makes historical cohort designs accessible. The large samples at baseline also 
enable us to study rare outcomes like mortality and disability pension award. Cohort studies 
are generally prone to selection bias arising from incomplete follow-up. The possibility of 
record linkages in Norway reduces this problem as outcomes can be identified in complete 
national registries. This possibility of record linkage is obviously an advantage for cohort 
studies that exists in very few countries, Norway being among these. For example, in the 
famous Barker study (243), outcomes had to be traced by names and addresses in the local 
environment of the hospitals where “small for gestational age”- babies were born. Lack of 
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record linkage possibilities also limits application of this design in for example the NCS (12, 
13).  
For the studies on mortality, the only source of dropout was emigration from Norway. 
In prediction of disability pension award, private early retirement and mortality were sources 
of dropout which we were unable to address.  
Confounding is generally a problem in cohort studies. However, as the HUNT study 
covers many aspects of health and social demographics, we were able to adjust for a whole 
range of relevant confounding factors in the prediction of mortality and work-related 
disability.  
Choosing a study population for a cohort study often represents a compromise 
between validity and generalizability (242). For example, the effect of smoking on mortality 
(245-247) and dementia (248) was studied in British medical doctors because valid measures 
of relevant variables could be obtained in this sample. Similarly, effects of psychological 
distress on coronary heart disease were studied among British white colour employees, the 
Whitehall II Study (175). With reference to the population-based design, it is commonly 
argued that the generalizability is good in the HUNT-2 study. However, non-participants 
differ from participants (211, 212), and Nord-Trøndelag is not fully representative for Norway 
(or Europe), being less urban and less educated, limiting the generalizability of the study.  
Mental illnesses commonly have a long-lasting or chronic course with recoveries and 
relapses. The HUNT study was performed at a fixed point of time, irrespective of variations in 
the mental health status of participants. Consequently, the design is biased towards including 
long-lasting conditions rather than brief episodes. For example will recurrent depressive 
disorders (F33) and dysthymias (F34.1) within the year of the health screening be captured by 
HADS in HUNT more often than would depressive episodes (F32) (35), simply because the 
longer mental disorders are lasting, the more likely they are to be present at the health 
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screening. In line with the DALY methodology (14, 15), it might be fair to argue that longer 
lasting conditions are more severe, and the over-sampling of individuals with long-standing 
conditions might therefore be adequate.  
 
2.6 Statistical analyses  
2.6.1 Logistic regression analysis  
Logistic regression models (249) were applied in all analyses of effect of anxiety and 
depression on mortality and disability pension award. The logistic regression model is similar 
to the linear regression model, the difference is that in the case of logistic regression one is 
modelling on and predicting the log of the odds of the outcome (mortality or disability 
pension award) rather than the absolute value of a continuously distributed outcome (250). 
Multiple logistic regression models have been applied with the purpose of controlling for 
confounding while testing for hypothesized effects of anxiety and depression on disability 
pension award and mortality. In predicting disability pension award, logistic regression 
models were also applied for exploratory purposes to develop a parsimonious model.  
 When using logistic regression models, relative risks are reported by odds ratios (OR). 
Strictly speaking, odds ratio values are only approximations to relative risk. For skewed 
dichotomies (for instance as regards infrequent diagnoses), however, the approximations are 
rather good. However, a high relative risk for a rare exposure has impact on few individuals. 
Therefore, associations between the exposure and outcome might also be described in terms 
of population attributable fractions (PAFs), which signify the proportion of incident cases in 
the population which would have been prevented if a causal exposure were removed, 
assuming an unconfounded causal association (242). Both measures are applied when 
appropriate in the analyses.  
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 Cox proportional hazard regression models were not applied due to three reasons: The 
proportion of censored individuals at the end of the follow-up period is higher than is 
recommended for employment of Cox regression models; mortality and disability pension 
award is after all rare outcomes within the available follow-up time. Second, the semi-
parametric modelling of time in Cox regression models is perhaps not entirely applicable 
when the dates of exposure and outcome are difficult to establish (250). Obviously, we have 
information as to date of death, date of award of disability pension, and date of the health 
screening in HUNT. But the exposure variables of interest measure mental disorders chronic 
of nature (hence discussion in chapter 2.5), so employment of the HUNT data as date for 
exposure might be arbitrary (compared to for other conditions with more discrete dates of 
onset, e.g. myocardial infarction). Mortality is obviously relevant to define by date, but 
disability pension award is a long-lasting process, where the decision of disability pension 
award is perhaps made by the applicant (or the physician) long before award of disability 
pension, hence the discussion in chapter 1.3.3 and 1.3.4. Third, in post-hoc argumentation, the 
effect of the exposure measures on outcome was not moderated by follow-up time, perhaps 
due to the chronicity of anxiety and depression. Consequently, logistic regression models 
were applied instead of Cox proportion hazard regression models.  
 Another statistical issue concerns our use of sumscores, which are consistent with 
formative measurement models for the exposures rather than analyses of latent variables, 
which are consistent with reflexive measurement models. It is perhaps more accurate to 
analyse anxiety and depression assuming reflexive measurement models, but as the outcome 
is dichotomous, available software has until recently been limited. The consequence of 
employing regression analyses of simple (or weighted) sumscores instead of structural 
equation modelling with latent variables is that we underestimate the true effects of anxiety 
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and depression on the outcomes of interest. It is, however, debated whether reflexive 
measurement models are appropriate for analyzing measures of mental disorders (251).  
 There are multiple presumptions of relevance as to the logistic regression model 
concerning specification of the model, measurement errors and error terms (252, 253). The 
probably most important presumption for the present studies relates to that no relevant 
confounders should be excluded; this to avoid overestimating the effect of the exposure on 
outcome. This has probably been a problem in literature on mortality (169), and is perhaps 
better covered in the present analysis. However, as multiple factors are associated with the 
outcomes and exposures of interest, this presumption will always be violated. Further, 
possible mediating factors (being on the causal pathway between mental disorders and 
mortality and disability pension award) should not be included in the model as confounders 
(250, 254); this to avoid underestimating the true strengths of the associations between 
exposure and outcome. This is further discussed in chapter 2.6.3. The problem of colinearity 
(250, 252), resulting from strongly correlated confounders is avoided by careful examinations 
of associations between independent variables, and examination of coefficients of tolerance 
(defined as one minus explained variance by all but one independent variable in prediction of 
the excluded one) in explorative linear regression analyses with outcomes as dependent 
variables. No problem of colinearity was identified. The issue of measurement errors and 
residual confounding for all involved variables will be covered in chapter 2.6.2.  
  
2.6.2 Measurement errors and residual confounding  
There are obviously measurement errors regarding exposures (as discussed in chapter 2.2) and 
confounders. Measurement error in mortality in itself is obviously minimal, but identifying 
the correct underlying cause of death poses several problems. In addition to random 
misclassification of mortality diagnoses, there are probably also biases, as presented in 
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chapter 1.4.1, 1.4.2, and 1.4.3. Regarding disability pension award, measurement errors are 
likely to be minimal, but the problem of validity is as mentioned in chapter 2.3.1 highly 
relevant. 
 Measurement errors relating to misclassification of mental disorders are likely to be 
random (250), and the consequence of this is limited to weakening of associations with 
outcome variables.  
 Measurement errors of confounding and mediating factors are also relevant (as 
described in chapter 2.4) at the stage of appraisal. Measurement error in a confounding factor 
obviously reduces the effect of the adjustment of the association of interest, with the 
consequence that we are probably underestimating confounding in all analyses (255).  
 The issue of residual confounding is an important consideration for interpretation of 
results. Any measurement error of the confounding variables will reduce the effect of 
adjustment on the association of interest (255). As discussed above (chapter 2.4.1), this also 
applies to rather objective entities, like having a cancer diagnosis (233) and medical 
examinations. For example, to reduce measurement error, all participants in HUNT-2 had 
their blood-pressure measured twice after an initial measurement not recorded (207). The 
blood-pressure was in the end defined as the mean of the two last measurements.  
 
2.6.3 Confounders versus mediators  
Confounders and mediators are described in chapter 2.4. Statistically, confounders and 
mediators are treated alike, but interpreted differently. All relevant confounding factors must 
be associated with both the exposure and outcomes of interest, and not be on the causal 
pathway between exposure and outcome (250, 255). Alcohol consumption is, for example, 
from clinical experience known to be increased in anxiety. To the extent increased alcohol 
consumption is a consequence of anxiety; it is positioned on the causal pathway between 
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anxiety and e.g. disability pension award, and accordingly a mediator rather than a 
confounder. This could possibly apply to several other variables of interest, in particular 
somatic symptoms.  
 Treating variables that are fully or partly mediators as confounders, causes us to 
underestimate the true effect of anxiety and depression on the outcomes of interest.  
 
2.6.4 Choice of cut-off for case-level anxiety and depression  
The applied cut-off for case-level anxiety or depression of 8 or higher in both scales has been 
described in chapter 2.2.3. Dose-response associations (242) are often reported between 
mental disorders and outcomes. Consequently, higher cut-off for case-level will strengthen the 
association of interest. This precludes direct comparisons of effect sizes among studies 
applying different case-levels for mental disorders.  
 
2.6.5 Moderators  
Hypotheses on effect-moderation by age and gender in all associations between exposures and 
outcomes were tested. Also, hypothesis on a buffer-effect in anxiety comorbid to depression 
was examined in the general mortality paper. All tests of interactions were performed with 
both the exposure variable (e.g. depression) and the hypothesized effect moderator (age) 
operationalized as dichotomies, and included as a product in addition to both variables alone 
(main effects). The applied test of significance was the increase in F-value in the regression 
model when adding the interaction term to all other relevant variables. This is a more 
conservative test of statistical significance of effect moderation than the t-test of effects from 
the interaction term.   
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2.6.6 Weighting procedure for somatic symptoms and somatic 
diagnoses  
Items comprising indexes for somatic symptoms and diagnoses were weighted for their 
relevance to outcomes, as described in chapter 2.4.1 and 2.4.2. Weights were established 
employing linear regression models. Regression coefficients were used as weights, and the 
indexes were computed as a sum of products between the standardized symptoms and 
diagnoses and their weights. All analyses were also performed applying un-weighted sum-
scores, and these generally explained less of the effects of exposures on outcomes. The 
indexes were generally used as continuous and ordinal measures.  
 
2.7 Ethics  
The HUNT study (including all sub-studies) was approved by the Data Inspectorate of 
Norway and recommended by the Regional Committee for Medical Research Ethics (region 
four, REK-4). Each participant signed a written consent regarding the screening, subsequent 
control and follow-up, and with regards to the use of all data for research purposes. They also 
consented to linking their data to other registers. This issue is, however, also subject to 
approval of the Data Inspectorate for each record linkages of data sources. All involved 
researchers work with files where names and personal identification numbers have been 
removed (207).  
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3 Results  
3.1 Anxiety and depression predicting disability pension award   
Of the 45 782 participants in HUNT aged 20-66, 1065 were awarded disability pension during 
the two year follow-up starting 6 months after the health survey.  
In summary, we found that anxiety and depression at baseline were strongly associated 
with subsequent award of disability pensions, an effect only partly explained by adjusting for 
comorbid somatic symptoms and diagnoses. The effect of comorbid anxiety depression was 
stronger than that of either anxiety or depression alone, probably from being an additive effect 
from the higher mean total symptom in comorbid cases. The effect of psychological morbidity 
appeared to be stronger for younger persons (20-44) than older (45-66). We found no effect-
moderation for gender.  
Anxiety and depression were also strongly and independently associated with 
disability pensions granted for physical conditions and diagnoses, indicating that 
administrative data may have underestimated the contribution of mental disorders to the 
award of disability pension.  
In the parsimonious model included, we found that the strongest independent predictor 
of disability pension award for any reason was age (PAF of 0.60), followed by somatic 
symptoms (0.37), not being active in any voluntary organizations (0.18), somatic diagnoses 
(0.16), educational level (0.14), work-status (0.08), anxiety and depression (0.07), and 
physical inactivity (0.05). Alcohol consumption, not having enough good friends, and living 
with a partner did not explain disability pension award in the fully adjusted model, and were 
therefore not included in the model presented.  
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3.2 Anxiety and depression predicting general mortality  
Of the 61 349 participants of 93 138 eligible for the study, 2 309 died during the follow-up 
period (mean 4.4 year follow-up time). Non-participants were older, more likely to be 
institutionalized or in hospitals and the mortality rate during follow-up in non-participants 
was higher than in participants (15% versus 4%).  
Case-level depression was found to be a risk factor for general mortality, robust for all 
available adjustments. Factors confounding the association, listed in descending order from 
the strongest confounder, included somatic symptoms and diagnoses, physical impairment, 
physical activity, smoking and alcohol problems, educational level and socioeconomic status, 
and physical measures (blood-pressure, cholesterol level, and BMI). There was a dose-
response association between depression symptom load and mortality, with increasing 
mortality with increasing severity of depression, particularly within the clinical range of the 
scale (range 8-21 on HADS-D).   
The association with anxiety scale scores, however, was U-shaped, with higher 
mortality in individuals with both low and high levels. Adjusted for physical health, we found 
no association between case-level anxiety and mortality.  
Depression alone was a stronger risk-factor for mortality than was comorbid anxiety 
depression, and this interaction effect remained statistically significant after adjusting for 
relevant confounders.   
The association between depression and mortality was equal in men and women, but 
stronger in participants aged 65 and younger than among those older.  
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3.3 Anxiety and depression as risk-factors for cause specific 
mortality  
Employing the same empirical material as in the general mortality paper, the last paper 
expanded the analysis to also examining causes of death. In the first analysis, we compared 
CVD mortality versus all other causes combined. We found no difference between the effect 
of depression on CVD and the effect of depression on other causes of mortality (OR=1.67 and 
1.66, respectively), and confounding factors were markedly similar. Unlike depression, 
associations for anxiety and comorbid anxiety depression showed some differences between 
CVD and other cause mortality: Adjusted for age and gender only, anxiety and comorbid 
anxiety/ depression were not associated with CVD mortality, but weakly associated with other 
cause mortality (OR=1.25 and 1.64 for anxiety alone and comorbid anxiety depression, 
respectively). 
We further subdivided cause of death into 11 groups in addition to CVD mortality, 
performing nested logistic regression analyses for all these separate groups. Case-level 
depression predicted mortality for all diseases except smaller groups for other diseases 
(N=71) and gastro-intestinal diseases (N=47). 
Whereas most disease-related mortality was only associated with depression (and not 
with anxiety or comorbid anxiety depression), the picture was different for external causes of 
death: Comorbid anxiety depression predicted suicide, accidents, and mortality without any 
certificate. 
Suicide accounted for very little of the effect of depression on mortality, being a rare 
cause of death (29 out of 2309 deaths), and being preceded by case-level anxiety and/or 
depression in only 12 of these. 
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4 Discussion  
 
4.1 Main results   
The three papers all concern long-term consequences of anxiety and depression with the 
following main results:  
1. All three papers indicate that long-term consequences of depression are underestimated: 
(i) In the disability paper, this is indicated by the independent association between 
depression and subsequent disability pension allegedly awarded for somatic diagnoses 
only. (ii) The effect of depression on general mortality has been questioned in literature 
reviews (e.g. 169), due to poor adjustment for confounding factors in most studies 
available. The general mortality paper shows a positive effect of depression on mortality 
after adjustment for a comprehensive list of possible confounding factors. (iii) As for 
cause specific mortality, present evidence of effects from depression is largely limited to 
CVD mortality and suicide. The cause specific paper indicates that depression is a risk 
factor for mortality in general not specifically related to suicide and CVD mortality.   
2. Whereas depression seems to be a general risk factor in relation to disability pension 
award as well as general and cause-specific mortality, the effect of anxiety varies across 
these outcomes: The general expectation from the literature would be that anxiety alone 
has an independent effect on adverse outcomes comparable to that of depression alone (as 
described in chapter 1.1.2), and that comorbid anxiety depression would be more strongly 
associated with the outcomes of interest than either alone (hence chapter 1.1.4). This 
pattern is found in cross-sectional analyses of HUNT-2 data employing HADS with self-
reported somatic conditions as outcomes (57). The findings for disability pension award 
were in accordance with this hypothesis; both anxiety and depression independently 
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increased disability pension award, and highest risk was found in comorbid anxiety 
depression. For mortality, however, the results were markedly different from the 
expectations: The weak effect of case-level anxiety was entirely explained by adjustment 
for depression. Anxiety symptoms measured by a continuous variable was negatively 
associated with mortality, but a better fit with data was observed using a U-shaped model. 
Finally, comorbid anxiety depression decreased mortality compared to depression alone.  
3. Also the effect of somatic symptoms and somatic diagnoses differed strongly between the 
outcomes: While somatic symptoms were a far stronger predictor for disability pension 
award than somatic diagnoses, the opposite was found for mortality. The same was 
observed for confounding: Somatic symptoms confounded the effect of anxiety and 
depression on disability pension award more than somatic diagnoses, while the opposite 
was found for mortality.  
4. The effects of mental symptoms on both mortality and disability pension award were 
stronger in the younger than the older part of the HUNT-2 population. No effect-
moderation was found for gender in either of the outcomes.  
 
4.2 Strengths  
As the three papers share exposure and most confounding variables and historical cohort 
designs are used in all papers, strengths are principally the same across the papers, and most 
of them are presented in the manuscripts. Mainly, the strengths of the three studies arise from 
the cohort designs. The study-sample is large and the participation-rate at baseline was high. 
Both measures of exposure and outcomes are relatively unbiased. The process of screening 
for anxiety and depression was double-blind (in terms of randomized controlled trails), that is, 
neither participants nor administrators were aware of the specific research hypotheses in these 
studies at baseline health screening. Ascertainment of outcomes at follow-up was obtained 
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from national registries, which are complete registries with the exception of emigration from 
Norway, and also independent of exposure status. As several somatic and socio-demographic 
variables were included in the health surveys, we were able to adjust for many factors 
expected to confound the associations.  
  
4.3 Limitations  
Parallel to the strengths of the studies, most of the limitations are also common across the 
three papers. Detailed aspects on operationalizations of anxiety and depression from HADS, 
and the corresponding gains and losses, are due to format and journal guidelines, not 
thoroughly covered in the papers. This will be described in more detail in the following, and 
the most important limitations in the papers will be presented.  
 
4.3.1 Operationalization of anxiety and depression from HADS  
Operationalizations of anxiety and depression from a screening instrument based on symptom 
count and symptom severity, like the HADS, give rise to a number of limitations. The 
operationalizations employed, included conventional cut-offs for each scale separately (two 
dichotomous variables), a nominal variable with four categories for case-level anxiety and/or 
depression, continuous measures, quadratic terms of continuous measures (for examination of 
U-shaped associations), cut-offs for quartiles, and by cut-offs for severity within the clinical 
range of each scale (details described in chapter 2.2.3). Restrictions on word counts of 
manuscripts in international journals do usually not allow for examinations of associations 
across various operationalizations. The model's ability to describe the association between 
exposure and outcome is obviously restricted to the model specified, including the limitations 
from operationalization of exposure. For disability pension award for example, we reported 
only results based on the four category nominal variable defining anxiety, depression, 
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comorbidity and a reference group. In this model, we were not able to demonstrate the factual 
dose-response association between exposure and outcome. In a dose-response association, 
recoding the exposure into a dichotomy restricts the variance, which in turn reduces the 
strength of the observed association. 
By definition, the number and severity of symptoms are higher in comorbid anxiety 
depression than any of the two alone. We found that comorbid anxiety and depression carried 
a higher risk for disability pension award than any of the two alone, but the specified model 
did not allow for any examinations on whether this is a result of higher symptom load in 
comorbid cases than those with anxiety or depression alone.  
An inherent limitation to any quantitative approach is the problem of measurement 
error, which in these data is likely to be random (213, 250), but also contributes to an 
underestimation of the true associations. However, bias cannot be excluded, and might occur 
from the missing substitution procedure (where a maximum of two missing values on each 
sub-scale are replaced with that individual's mean on the valid items) (77). Further, bias might 
stem from under-report of symptoms as a consequence of denial. Both these possible biases 
are in the direction of underestimating the true symptom load. Employing categorical 
measures, measurement error might imply misclassification in symptom-loads around case-
level, resulting in arbitrary classifications (41).  
As is inherent from the observed distribution of reported symptoms in HADS, co-
occurrence of symptoms of anxiety and depression is not only relevant above case-levels, but 
occurs also at sub-threshold levels. The HADS total sum-score of 14 can be split into two sub-
scores of 7, alternatively as 9 and 5, translating into reference group or case on one sub-scale 
respectively. For most adverse clinical outcomes, anxiety and depression have the same 
correlates (e.g. 57), and comorbid anxiety depression is more strongly associated with such 
outcomes than any of the two alone (probably due to higher total symptom load). There is 
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little evidence that an even distribution of symptoms on anxiety and depression (hence the 
example of 7 on each sub-scale) involve less psychopathology than an uneven distribution 
(e.g. the second example with 9 and 5 on subscales). Consequently, it might be argued that 
employment of case-levels for anxiety and depression separately will consistency under-
recognize comorbid sub-threshold psychopathology (41). This objection applies not only to 
HADS, but also to diagnostic classifications like ICD-10 and DSM-IV. A one-dimensional 
symptom load for anxiety and depression comprised is an obvious alternative. The results 
from the general mortality paper, however, provide a rare example of a correlate being 
markedly stronger on one dimension (depression) than the other (anxiety).  
Beyond general problems with dichotomization of symptom-scores for anxiety and 
depression, there are specific problems with any choice of cut-offs. As described in chapter 
2.2.2, case-level with cut-off at 8 is across studies found to give a sensitivity and specificity of 
0.80 on both sub-scales (56). Despite accordance in the literature, at least two problems apply 
to this convention: As demonstrated in the general mortality paper, the strength of the 
association increases with higher cut-off levels, which is a logical consequence given a dose-
response association. This problem precludes comparisons of effect-sizes across studies 
employing different means of case identification or cut-offs, e.g. the many studies of 
depression on mortality where the mental health is based on clinical interviews. Further, it is 
not self-evident that the cut-off for a condition should be defined aiming at equal sensitivity 
and specificity. As the prevalence of non-depressed individuals is higher than the prevalence 
of depressed, a cut-off for equal sensitivity and specificity will identify more false negative 
cases than false positive ones, and often more false negative than true positive. Lowering the 
case-level would simply include more false positive cases, and vice versa.  
Screening instruments for anxiety and depression are often criticised for lacking the 
added reliability from clinician's evaluations, hence the discussion in chapter 2.2.2. As 
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mentioned there, HADS is better than an unstructured clinical evaluation of anxiety and 
depression dimensionally across two dimensions (218). However, fully structured clinical 
interviews, like employed in the NCSs (11-13) and the Norwegian replication (7), not only 
increase reliability, but also provide more detailed diagnoses. For example, one item in the 
HADS anxiety subscale measures panic attacks, and the other six items cover symptoms of 
GAD. The anxiety subscale has also been found sensitive to other anxiety disorders (57), but 
cannot differentiate between these. Screening tools are designed either to screen for probable 
cases or to be used as scalable measures in their own right (213). HADS is in this study and 
elsewhere used as both.  
Most of the above mentioned limitations relate to HADS employed as a categorical 
measure. Employment of HADS as a continuous measure is often the suggested antidote, but 
again, there are problems with this approach as well: It is commonly argued that symptom 
rating scales for psychopathology are ordinal rather than arithmetic, i.e. that the difference 
between a HADS depression score of 7 versus 10 does not translate into the difference 
between 3 versus 6 (213). Further, associations between exposure and outcome might not be 
linear, as demonstrated with depression on general mortality. Finally, with few exceptions 
(e.g. Psychosomatic Medicine), journals within psychiatry and medicine seem to favour 
categorical operationalizations above continuous. This as discussed in the chapter on 
continuous versus discrete measures in psychiatry (chapter 1.1.3).  
In conclusion, there are limitations to all opearationalizations of mental disorders. The 
common use of separate dichotomies for anxiety and depression are perhaps more a 
convention than optimal operationalizations in a psychometric sense. The perhaps best 
approach is to examine associations between exposure and outcome applying multiple 
operationalizations of anxiety and depression, with particular attention to strength and shape 
of associations and issues of comorbidity between anxiety and depression. This multi-analysis 
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approach must, however, be weighted against the increasing risk of type I errors when 
multiple tests are performed.  
 
4.3.2 Residual confounding  
The issue of residual confounding applies to all three papers. Information on somatic 
diagnoses and symptoms in the base-line screening is self-reported, and the categories used 
are not exhaustive. Consequently, the effect of somatic diagnoses and symptoms may be 
somewhat underestimated, and the effects of anxiety and depression, when adjusted for 
somatic symptoms and diagnoses, overestimated. This issue of residual confounding resulting 
from problems of reliability and variables not covered also applies to other confounding 
variables included, e.g. health related behaviour, biological health-related measures, and 
variables on socio-demographics.  
 
4.3.3 Over-adjustment  
As described in chapter 1.2, there exists the complex relationship between psychiatric and 
physical disorders. HADS includes no somatic symptoms of anxiety or depression and 
identify symptom load on the mental or cognitive aspects of anxiety and depression only. By 
later adjusting for somatic symptoms, we attempt to disentangle mental from somatic 
symptoms. HADS was developed for screening for mental symptoms in contexts of somatic 
disease (49), and somatic symptoms of mental disorders were excluded to avoid false positive 
cases in these settings as inclusion of somatic symptoms could give a ceiling effect. This 
feature makes HADS particularly suitable for disentangling the effect of pure mental 
symptoms from somatic symptoms and somatic conditions, if the major concern is 
confounding by these somatic factors. However, using this approach, we probably over-
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adjusted our model, and thus under-estimated the effects of anxiety and depression upon 
disability pension award for physical conditions. This is so because several of the somatic 
symptoms might be manifestations of the psychiatric disorder (84). Somatic symptoms are 
common in mental disorders, and also part of diagnostic criteria according to ICD-10 and 
DSM-IV. The over-adjustment from employing this approach is therefore likely to be notable. 
For three reasons, this problem is perhaps more evident when predicting disability pension 
award than mortality: Somatic symptoms are by definition more than somatic conditions 
closely related to mental disorders; somatic symptoms have independently a strong effect on 
disability pension award; and adjustment for somatic symptoms attenuate the effect of mental 
disorders on disability pension award more than on mortality.  
 Why, then, do we specify a model so that over-adjustment is likely to occur? There are 
at least two reasons for this: As researchers, we are obliged to attempt to falsify our 
hypotheses, which include searching for alternative explanation for the hypothesized 
associations. The more thorough attempts to adjust for somatic confounding factors, the more 
likely over-adjustment will be. Partially, this is caused by the power balance between medical 
disciplines, where the burden of proof can be claimed to rest heavily on mental health 
disciplines. As a practical example, in the review process re-submitting the disability paper to 
the American Journal of Psychiatry, most of the discussion concerned residual confounding 
stemming from symptoms and conditions not available for inclusion in the model. The 
weighting procedure (described in chapter 2.6.6), where somatic conditions and symptoms 
were weighted for their relevance for sick-leave last year (and correspondingly for mortality 
in the mortality papers) was a result of this discussion with the reviewers. The weighted sum-
scores of somatic symptoms and somatic conditions explained slightly more of the effect of 
exposures on outcomes in all three papers. Yet another source of over-adjustment resides in 
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that we adjusted for health-related behaviour (e.g. smoking, alcohol consumption, and lack of 
exercise) that may be causally related to anxiety and depression.  
This tradition of over-adjustment when examining correlates to mental disorders is 
commonly requested by reviewers in psychiatric journals, and might reflect the power-
balance between psychiatry and other specialities in medicine, perhaps illustrated by Eaton's 
formulation that psychiatric diseases tend to be defined by failure to locate a physical cause 
(95, referred in 96).  
 
4.3.4 Protopathic bias  
Early symptoms in development of somatic illness not yet diagnosed can be confused with 
symptoms in mental illness. The tendency to incorrectly diagnose mental disorder in this 
situation is called protopathic bias. This bias might apply to all three papers, as we have no 
measures of onset of somatic diagnoses after the HUNT-2 screening. Thus can the effect of 
anxiety and depression on mortality and disability pension award for somatic diagnoses be 
overestimated. But for all outcomes, we examined if the effect of the exposure was different 
in the first versus the second half of the follow-up, and while none of these were significant 
there were weak and un-significant trends of the effect declining over time. We are able to 
discount protopathic bias emerging from physical conditions that give rise to psychiatric 
symptoms from these findings.  
 
4.3.5 Biased non-participation in HUNT  
Several reasons were reported for non-participation in the HUNT study, including both good 
health and lack of time in young individuals, and also poor health in elderly (211). Our 
finding of strongly increased mortality in non-participants is obviously indicating a strong 
participation bias in the direction of good health. Regarding mental health, there are reports of 
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more psychopathology among non-responders to general health surveys (212). We have no 
information on the rate of disability pension among non-participants. This healthy-participant 
bias restricts the variance in both exposure and outcome, and consequently increases the 
likelihood of underestimating true associations between exposures and outcomes.  
 
4.3.6 Stronger symptom stability in GAD than in depression  
As GAD typically follows a more chronic course than depression; the risk of misclassifying 
individuals with depression (e.g. those being in remission between depressive episodes at the 
screening) surpasses the corresponding for anxiety. This limitation, being relevant across all 
three papers, precludes direct comparison of effects of anxiety with effects of depression upon 
disability pension award. However, the problem is limited by the cross-sectional design in the 
general population being more prone to identify chronic cases than shorter episodes. This 
issue is described more in detail in chapter 2.5.   
 
4.3.7 Limitations specific to the disability paper  
There are a number of particular limitations in the disability paper, many of whom relate to 
issues of validity of the disability pension award as a measure of work-related disability.   
As discussed in the paper, the number of diagnoses reported by general practitioners 
(GPs) in an application for disability pension is limited to two. Our analysis of anxiety and 
depression as predictors of disability pension awarded for alleged non-psychiatric diagnoses 
only is limited to the physicians’ skills in correctly identifying primary and secondary 
contributing diagnoses. In cases where GPs intended to report mental diagnoses, but were 
hindered by the restriction of a maximum two applicable diagnoses, this might contribute to 
over-estimation of the effects in this analysis. However, this problem is limited as F-
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diagnoses, when used, usually (in 73%) is reported as primary diagnosis. Further, 46% of 
applications reported one diagnosis only.  
A perhaps more important concern is the validity of the outcome measure as a measure 
of health-related disability. This argument applies for causes for disability pension beyond 
health and impairment, but also for impairment in the economically inactive part of the 
population: Despite the restriction that disability pension should be awarded only for work-
related impairment attributable to a diagnosable condition, there are several identified risk 
factors for disability pension award beyond health. As described in chapter 1.3.4, these 
include push-factors, for example factory closings (142) and downsizing (111). There is 
support for the hypothesis that disability pension is used for early retirement (143), which also 
could be supported from the strong independent effect of age on disability pension award in 
our study. Such use of health related benefits is an example of medicalization where problems 
on a structural level find its solution by implicating the individual and benchmarks the 
individuals health as the factor leading the individual out of the work force (144).  
In addition to push-factors, the conundrum of an increase in disability pensioning that 
is observed alongside improvement in key health indicators (134), has stimulated arguments 
using a pull model (123), hypothesizing that disability pension is a result of rational choice, as 
described in chapter 1.3.4. Despite limited empirical evidence, the existence of applicants 
with primarily economic motives cannot be excluded. All these factors limit the validity of 
disability pension award as a measure of work-related disability from decremented health in 
terms of specificity, and contribute to under-estimation of the true effect of anxiety and 
depression on work-related disability.   
In addition to factors beyond health-related impairment being causes for disability 
pensioning, the opposite cannot be excluded, namely that medically impaired economically 
inactive individuals are provided for by family members and do not apply for disability 
 92 
pension. Erroneously rejected applications could also add to this, as well as sickness presence 
(133). All these factors limit the sensitivity of disability pension award in measuring work-
related disability, and further contribute to under-estimation of the true effect of anxiety and 
depression on work-related disability.  
Finally, to what extent the results of the disability study are applicable for 
generalization, can be questioned. The disability pension schemes in Norway are similar to 
other OECD countries, and secular increases in psychiatric diagnoses in new cases have been 
reported throughout these countries (134). However, Norway is among the countries in the 
OECD region with the highest proportion of individuals within working age on disability 
pension. The fact that public expenditure on disability benefits is relatively higher than 
expenditure on unemployment benefits in Norway than in any other OECD country (134) is 
also an indication that the bias in direction of medicalization is strong in Norway.  
These issues obviously limits generalization, but on the other hand, if the higher 
proportion of disability pensioners truly reflects causes beyond health, we probably have 
underestimated the relative effect of anxiety and depression on disability pension award 
compared to other OECD countries.  
 
4.3.8 Limitations specific to the mortality papers  
As described in chapter 2.1.3 and 2.3.2, information on mortality is reliable and complete, and 
consequently does not introduce any major additional limitations. The reliability in 
determining the underlying cause of death is, however, questionable, and consequently a 
limitation of the study. There are reports of trends in causes of mortality, like an alleged 
decline in suicide in Norway from 1990 till 2000 (166). However, this should be discussed 
with reference to a parallel increase in mortality from causes where occasional 
misclassifications of suicides could occur (as discussed in chapter 1.4.3). If this bias is 
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present, we have underestimated the effect of suicide from anxiety and depression. This will 
be discussed in more detail in chapter 4.6.2.  
 
4.4 Relations between the two outcomes disability pension award 
and mortality  
4.4.1 Disability pension award and mortality both relate to health  
Both disability pension award and mortality can largely be regarded as adverse outcomes of 
exposures relating to health. Although, according to public registries, 5.4% of all deaths were 
from external causes and not illnesses (see discussion in chapter 1.4.3). This proportion is 
strongly associated with age, with a higher proportion of non-illness mortality in younger 
individuals. Disability pension award is also caused by factors beyond impairment from 
health problems as described above in chapters 2.3.1 and 4.3.7.  
 The findings across the three papers indicate how aspects of health relate to mortality 
and disability pension award. As described above (chapter 4.1), depression increases both 
outcomes, while the role of anxiety, somatic symptoms, and somatic diagnoses differ 
throughout the three papers. In summary, both outcomes are related to health, but evidently to 
different aspects of and factors beyond health. 
 
4.4.2 Are there any associations between disability pension award and 
mortality?  
Given that disability pension award and mortality both are outcomes related to health, a 
positive association between these two might be expected. However, as described above in 
chapter 4.1, they relate partly to different health characteristics which suggest a not very 
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strong association. In particular this is the case for somatic symptoms that were strong 
predictors of disability pension award, but only weakly related to mortality.  
 To the best of my knowledge, there are no studies of whether disability pension award 
increases mortality. However, from the Whitehall II prospective cohort study, having more 
than five certified sickness spells per 10 years increased mortality beyond the effect of self 
rated health, presence of longstanding illness, and a measure of common clinical conditions 
(256). The association between sick-leave and mortality was not linear, and a protective effect 
of a small number of self-certified absences was reported. The study justifies the hypothesis 
that disability pension award might increase mortality, but this is yet to be empirically 
examined. Beyond this study, we know very little about health-related consequences of being 
on disability pension (as discussed in chapter 1.3.2).  
According to the pull-perspective (123), being provided for by the public and having the 
days off work is an attractive position. We cannot exclude disability pension being a relief 
from harsh working conditions deteriorating health, which suggests a negative association 
between these two outcomes. It is, however, likely that disability pension for some leads to 
increased passivity and reduced social network, which could deteriorate health. As mentioned 
above (again in chapter 1.3.2), health consequences of sickness absence was the theme of the 
3rd pre-conference meeting at the EUPHA conference in Graz (November 9th 2005), and 
despite a consensus that there is little evidence of consequences of long term sick leave on 
health, most researches suggested hypotheses indicating a deteriorating effect of long-term 
sick-leave on health. These postulations might, however, be biased by that researchers 
perhaps personally are more invested in their work than is the common employee. 
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4.5 Interpretation of findings: Disability pension paper  
4.5.1 Is the impact of anxiety and depression on disability pension award 
underestimated?  
The main conclusion in the first paper is that the impact of anxiety and depression on 
disability pension award is underestimated compared to public statistics for diagnoses for 
award of disability pension. Across most OECD countries, approximately one third of 
disability pensions are awarded for mental disorders (any F-diagnosis according to ICD-10) 
(134), and in 2004, 28% of disability pensioners in Norway had a mental diagnosis in their 
application for disability pension. Limitations of this conclusion are covered above (chapter 
4.3), and include mainly issues relating to residual confounding.  
 Many physicians report that issues related to sick-leave can be problematic (113). 
Patients applying for disability pension award commonly present mixed and undefined 
symptoms. In Norway, muscle-skeletal disorders was the largest diagnostic group (39.1%), 
followed by mental disorders (28%) in 2004 (30), but the proportion of disability pensions 
awarded for mental disorders has increased over the last decades (102, 134). As there is little 
evidence for an increase in mental disorders in the population (11), this increase is perhaps 
indicating increased recognition rather than trends in the prevalence of mental disorder. 
Alternatively, an increased effect of mental disorders on work-related disability resulting from 
brutalization of working life (111, 142) cannot be excluded.  
 Based on the finding that anxiety and depression were independent predictors of 
disability pension awarded for non-psychiatric diagnoses, we reached the conclusion that the 
impact of mental symptoms on disability pension award is underestimated as it appears in the 
medical certificates. The finding is obviously subject to the limitations discussed above 
(chapter 4.3), but the conclusion is supported by a number of other observations:  
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 In the parsimonious model in the same manuscript, the effect of somatic symptoms on 
disability pension award was very strong, and far stronger than somatic diagnoses, anxiety 
and depression. Some of this effect should be related to mental disorders, through somatic 
symptoms being part of the spectre of symptoms of mental disorders, but also through 
somatization disorders. How to label the effect of somatic symptoms that cannot by 
indications alone be attributed to somatic conditions and organic aetiology is also shown to be 
a question of which medical speciality is consulted, including mental health professionals (78, 
91, 92). It should, however, be quite uncontroversial to argue that at least some of the effect of 
somatic symptoms on disability pension award in general represents mental disorders. This 
relates to the discussion of how to define, understand, and label somatic symptoms (chapter 
1.2), and also to the issue of over-adjustment, perhaps reflecting the power-balance between 
medical specialities (discussed under limitations, chapter 4.3.3).   
 A secondary analysis based on the same data as the first paper examined if insomnia is 
an independent risk factor for disability pension award (257). Applying principally the same 
model as in the parsimonious model in the first paper, but also including anxiety and 
depression as possible confounding factors, we found an independent effect of insomnia on 
disability pension award to be not much weaker than the effect of anxiety and depression 
combined. Insomnia is not reported in any application for disability pension award registered 
among participants in the HUNT study, and we have not been able to identify this diagnosis in 
any public statistic over diagnoses for disability pension award (30). Consequently, also the 
effect of insomnia on disability pension award seems to be underestimated (257).  
 Another common mental disorder is substance dependence, in the general population 
dominated by alcohol dependence. This is not accepted as a diagnosis awarding disability 
pension (though medical consequences following alcoholism are). It would consequently be 
fair to hypothesize an independent effect of alcohol problems on disability pension award 
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along the same line of arguments as for the insomnia study (257). We did, however, exclude 
this variable from the parsimonious model in the first paper as it did not predict disability 
pension adjusted for the variables included. Alcohol problems are in the HUNT study 
measured with CAGE (234) and questions are framed in a lifetime perspective. The 
information about the study stated that identified high-risk groups would be targeted for 
clinical interventions (207). This may have compromised the sense of anonymity, which 
accordingly may have biased the responses to CAGE. Acknowledging these limitations, there 
is no evidence from this study that alcohol problems contribute to mental disorders and is 
underestimated as a cause for disability pension award.  
 British studies have showed that GPs' skills in recognising mental disorders are 
limited, and interventions aiming at improving this capacity through educational efforts have 
a detectable effect if measured dimensionally (258, 259). Similar positive effects of training 
on detection of depression have been found in care staff in nursing homes for elderly (260). 
This limited ability to recognize mental disorders is perhaps one reason that most individuals 
with case-level mental disorders report never having sought help (11, 45). A submitted 
Norwegian study based on secondary analyses of data gathered for a pharmaceutical study 
(218) indicates that general practitioners overestimate their ability to recognize mental 
disorders, and that there is no association between self-reported diagnostic skills (regarding 
mental disorders) and true skills (defined as concordance between GPs identification of major 
depression and GAD compared to external gold standards) (261). As presented in chapter 
2.2.2, HADS is a better case-finder for both anxiety and depression than GPs are among their 
own patients (218). Knowing that physicians tend to be biased by their speciality when facing 
patients with unclear somatic symptoms or absent organic aetiology (78, 91, 92), it is 
plausible to hypothesize that GPs are biased towards choosing somatic (e.g. muscle-skeletal 
diagnoses) before mental diagnoses (e.g. somatization) in patients fulfilling criteria for both. 
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Furthermore, we cannot exclude preferences among patients and authorities in the same 
direction.  
 According to public regulations in most OECD countries, medical rehabilitation 
(usually treatment as usual) must be attempted prior to disability pension award. Based on the 
studies examining GPs problems in detecting and treating mental disorders, we hypothesized 
that this problem also would be reflected in patients awarded disability pension for mental 
disorders. This hypothesis was examined in an ongoing study based on secondary analyses of 
the HUNT data on help-seeking for mental disorders (45), and results were recently presented 
at a conference (262): Thirty four per cent (95% confidence interval 30-39%) of the 
population awarded disability pension for a mental disorder five years prior to participation in 
HUNT reported never having received any professional help for mental disorders. An 
objection to the result is that patients might fail to self-report this kind of information or to 
have insight in what a treatment scheme is targeting. On the other hand, it is fair to expect that 
treatment in the face of a possible disability pension award to be comprehensive and explicit 
enough for the patient to be aware of what the interventions are aimed at. These findings 
might be regarded as a consequence of inadequate case-finding and treatment for mental 
disorders in primary care, and an indication of mental disorders being under-recognized for 
disability pension award.  
 As presented in the introduction (chapter 1.1.3), sub-threshold depression is found not 
only to increase sick-leave, but to account for more days of work than major depression (37). 
Obviously, the risk for sick-leave in major depression is greater than in sub-threshold 
conditions, but as the prevalence of sub-threshold conditions is higher than the prevalence of 
major depression, sub-threshold conditions account for more days of work than major 
depression. This can be demonstrated mathematically by employing population attributable 
fractions (242). There exist no such study for disability pension awards, but given that the 
 99
findings are of relevance to disability pension award, it is relevant for the line of arguments on 
the underestimated impact of anxiety and depression on disability pension. It is more likely, 
and perhaps also reasonable, that physicians (mostly GPs) fail to recognize sub-threshold 
depressive conditions than case-level depression, as sub-threshold conditions per definition do 
not fulfil diagnostic criteria. This failure in recognition is likely also reflected in applications 
for disability pensions, and consequently contributing to the underestimation of the impact of 
mental disorders on disability pension award on an aggregated level.  
 In summary, the finding that anxiety and depression are risk factors for disability 
pension award for non-psychiatric diagnoses is novel, while the conclusion that this represents 
an underestimation of the impact of anxiety and depression on disability pension award is 
supported by other studies.   
 
4.5.2 How do the finding of independent effects of mental disorders on 
disability pension award relate to the push- and the pull models?  
The position of health as a causal factor in disability pension award has been challenged on 
the background of observed increase in disability pensioning in most OECD countries parallel 
to the improvement in key health indicators (134). As mentioned in chapter 1.3.4, the pull 
model suggests that if sick-leave benefits are attractive, it will increase economically 
motivated applications. This perspective has had major influence on public policy in Norway 
(156). Employing the pull perspective, the health information obtained in the context of 
applications for disability pension award will be influenced by the applicant physicians’ 
choices of acting as the patients advocate or as a gate-keeper on behalf of society: In the role 
of patient's advocate, the physician can emphasise diagnoses that knowingly increases the 
chance of approval. Also, the validity of the diagnoses from physicians emphasizing the role 
as gate-keepers can be questioned, as most diagnoses for award of disability pension are based 
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on information presented by the patient. This problem also applies to the very relevance of 
health problems as primary motivation for applying for disability pension: From the 
perspective of rational choice theory (123), it is objected that report of health problems in the 
context of applying for disability pension award can be biased by economic incentives.  
 The disability paper provides relevant data for the debate between the push and the 
pull perspective: First, the health information reported in the HUNT study is not biased by 
possible economic incentives for disability pension award. Consequently, any prospective 
effect of health in the HUNT study on disability pension award is supporting the push model. 
In the discussion on push- versus pull model, this is particularly relevant for the effects of 
somatic symptoms, and perhaps also anxiety and depression, as these are all based on self-
reported symptoms. In conclusion, somatic symptoms and mental disorders combined, despite 
being vague and woolly (borrowing a term from Prince (213)), are more than three times 
stronger than somatic conditions in prediction of disability pension award, also when reported 
in a context without incentives for disability pension award. This is by far the largest study of 
its kind and also the most complete one with regard to measures of health and adjustment for 
confounding factors, and conclusions are generally in accordance with findings from previous 
studies (104, 229).  
As the push and the pull models must be regarded as conflicting, support for one may 
contribute to weakening the other.  However, as the two models can be empirically valid 
simultaneously, evidence in support of the push model can by no means falsify the pull 
model.  
 
4.5.3 How do anxiety and depression cause work-related impairment?   
The independent effects of anxiety and depression do probably increase work-related 
impairment in different ways relating to diagnostic criteria. Both anxiety and depression have 
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a whole range of aspects, and it is an empirical question if all of these or some in particular, 
are relevant for explaining the association with work-related disability. As discussed above 
(4.5.1), the brutalization of working life might increase the burden of continued work for 
individuals with mental disorder experiencing e.g. organizational changes or downsizing.  
By face validity, many symptoms of anxiety and depression might seem rather 
incompatible with work. Borrowing random items from the HADS scale (50): Being tense or 
wound up, having a frightened feeling as if something awful is about to happen, having 
worrying thoughts going through the mind, getting sudden feelings of panic, feeling slowed 
down, having no interest in ones appearance, finding no joy in things previously enjoyable, 
and not being able to look forward with enjoyment to things. These may all comprise work 
disability in a global fashion and not specifically.   
Beyond speculations on how anxiety and depression are characterized by thoughts and 
feelings incompatible with work, associated somatic symptoms encompass mental disorders 
and may contribute to limitations in work ability. Finally, the long-lasting or chronic course 
with recoveries and relapses in mental disorders increase the problem of impairment in work.  
 
4.6 Interpretation of findings: Mortality papers  
4.6.1 Contributions to the literature  
As described in the introduction (chapter 1.4.4), six questions were examined for the 
hypothesized effects of anxiety and depression on mortality:  
The very existence of an effect of depression on mortality has been questioned, based 
on possible residual confounding in a review of population-based studies (169), and that most 
reviews and meta analyses do in general base their estimates on poorly adjusted or crude 
estimates of effects of depression on mortality (21, 172, 200). We were able to address this 
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issue of confounding as the HUNT-2 study covered broader range of potential confounding 
factors. Weighting procedures of somatic diagnoses and symptoms by their association with 
mortality further increased our ability to adjust for confounding in this association. The effect 
of depression was highly significant in prediction of mortality even in the fully adjusted 
models, and despite possible over-adjustment, particularly regarding adjustment for somatic 
symptoms as discussed in chapters 1.2 and 4.3.3.  
The second question relates to whether severity of depression relates to mortality. A 
literature review suggested equal effect of major depression and sub-clinical forms of 
depression (172) on mortality. We found little variation in mortality within the first three 
quartiles of the depression scale. However, within the fourth quartile, there was a dose-
response association between symptom load and mortality. This finding is contrary to the 
conclusion in the referenced literature review.  
The third question relates to mechanisms hypothesized for the association between 
depression and mortality. Two main mechanisms are proposed (182), the first relating to 
lifestyle, namely that depression may be a distal risk factor related to a number of proximal 
risk factors that increase morbidity and mortality from CVD and other diseases. We were 
unable to identify any relevance of smoking, lack of exercise and alcohol consumption in 
relation to mortality, and our findings thus suggest marginal relevance of these factors as 
mechanisms underlying the association. Unfortunately, we had no information on non-
adherence to treatment strategies, also hypothesized as a mechanism underlying the effect of 
depression on mortality.  
The second main mechanism proposed (182) includes biological changes occurring in 
depression, e.g. increased cortisol, increased platelet coagulability and changes in heart rate 
variability (182). We were unable to adjust for these factors as they were not included in the 
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initial screening. They are, however, all strongly related to CVD mortality, and consequently 
less relevant for the effect of depression on mortality beyond CVD.  
Fourth, the studies add to the existing knowledge as to whether the effect of 
depression on disease mortality is specific for CVD: Most of the evidence on depression in 
relation to disease mortality has focused on CVD mortality; there exist meta analyses (21, 
196) of these associations, and even an review of potential mechanisms (191). This strong 
tradition might leave the impression that the effect of depression is specific for CVD 
mortality. Our finding that depression is no stronger a risk-factor for CVD mortality than 
other-cause mortality comprised, adds to the existing knowledge by indicating that hypotheses 
on underlying mechanisms for the association should not be limited to CVD mortality. 
Fifth, the general mortality study adds to the existing knowledge on whether the effect 
of depression on mortality is stronger in men than in women, which has been repeatedly 
reported (170, 201, 202), although generally not based on tests of interaction effects between 
gender and mortality in prediction of mortality (169). Despite stronger statistical power than 
any previous study examining the effect of depression on mortality, we were unable to 
confirm the hypothesized effect-moderation by gender. We did, however, find an effect-
moderation by age, with stronger effect of depression in young age. This issue has not been a 
major focus of attention in the literature.  
Finally, the study also adds to the present knowledge of the effect of anxiety on 
mortality. The literature on anxiety in relation to mortality is scarce but includes reports of 
both positive (203) and negative (204) associations. In addition, previous studies of 
depression in relation to mortality have generally not examined comorbid anxiety. Applying a 
linear model, anxiety is negatively associated with mortality, which is in line with a previous 
finding of a study also applying HADS (204). The remaining findings regarding associations 
between anxiety and mortality are generally new contributions to the literature. This includes 
 104
the findings that the effect of case-level anxiety on mortality was entirely explained by 
adjustment for depression (however not vice versa); the U-shaped association between 
symptoms of anxiety and mortality; and the lower mortality in comorbid anxiety depression 
than in depression alone. The lower risk in comorbid anxiety depression than in depression 
alone was contrary to our expectation as comorbid conditions generally are more strongly 
associated with adverse outcomes.  
 
4.6.2 How much of the effect of depression on mortality is accounted for 
by suicide?  
The cause specific mortality paper provided potentially important knowledge as to whether 
there are hidden suicides among other causes of death. The results supported suicide as a 
relevant mechanism underlying the effect of depression on mortality (200), but only in 
comorbid anxiety depression, thus indicating a different pattern than in disease mortality from 
depression. A similar pattern of comorbid anxiety depression predicted mortality without 
certificate (N=40) and accidents (N=80). This might indicate that the proportion of suicide 
among deaths is slightly underestimated.  
However, suicide accounts for very little of the effect of depression on mortality. Of 
the 2309 deceased individuals, 29 (1.3%) had suicide registered as their cause of death. Even 
if this is an underestimate, the effect of depression on disease mortality accounts for a much 
higher number of deaths from depression than does suicide. In summary, our results support 
suicide as a mechanism underlying the effect of depression on mortality, but indicates that this 
mechanism accounts for very little of the total effect of depression on mortality.  
As mentioned above (chapter 2.1.1), individuals with HADS sum-scores above 25 
points and a random sample of individuals with scores slightly below this cut-off were 
informed in writing and advised to see their general practitioner for further clinical tests and 
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eventually treatment (208). Also, general practitioners in the county were offered a simplified 
diagnostic instrument including a brief course. One of the main objectives of this intervention 
was to reduce suicide in the county through improved detection by screening employing 
HADS, and also improved treatment through educational programmes for GPs. The regional 
ethical committee did not allow a randomized controlled trail; consequently we do not know 
whether the intervention actually reduced suicide among those contacted. From the cause 
specific mortality paper we do, however, know that the majority (n=17, 59%) of those 
committing suicide during follow-up were neither cases of anxiety nor depression at the time 
of the screening. Twelve suicides were among a group of 3 640 individuals with comorbid 
anxiety depression at time of the screening, thus 0.3% of the total group, indicating a rather 
poor specificity of the HADS detecting potential suicides. Consequently, employing HADS 
with comorbid anxiety depression as positive screening criteria, a major screening task 
remains for physicians in primary care. As mentioned above, GPs' abilities to recognise 
mental disorders is limited (258), and a review of the literature on mental health education for 
primary care physicians concluded that long term outcomes were less positive (263), although 
secondary analysis of data from the Hampshire Depression Project (258) employing 
dimensional approaches indicated some effect (259). Training of care staff in residential 
homes for elderly has also been reported to increase detection of depression (260). In 
summary, we can conclude that (a) there were relatively few suicides (n=12) among those 
with comorbid case-level anxiety depression (n=3 640); (b) the majority of suicides (59%, 
n=17) were in individuals without case-level anxiety or depression at baseline; (c) detecting 
12 suicides among 3 640 screening positive from HADS implies a case-finding task for 
general practitioners, who are not the best case-finders in mental disorders; and (d) the case-
finding ability in GPs is not easily improved. Despite suggestions that increased utilization of 
antidepressants might reduce suicide rates (264), it might be fair to conclude that there is little 
 106
empirical ground for reducing suicides by interventions (like the one in HUNT-2 (208)) that 
involve screening for anxiety and depression in the general population with subsequent 
treatment in primary care.  
However, intervention (treatment or prevention) aiming at reducing depression in the 
general population might have impact on mortality, but more likely through reduced disease 
mortality than from preventing suicide.   
 
4.7 How can anxiety and depression as exposures be reduced?  
Studies from the US general population offer limited evidence for an increase in the 
prevalence of mental disorders (11). From British studies among adolescents there is evidence 
for an increase over the last 25 years in conduct problems, and perhaps also for a recent rise in 
emotional problems, but not for hyperactive behaviour (265). There is also little evidence for 
an increase in the impact of mental illness on adverse outcomes as disability or mortality, but 
there are some speculations over whether brutalization of working life increasingly expel 
individuals from the work-force. The mortality and disability pension studies for this thesis 
strongly indicate adverse outcomes of anxiety and depression. A plausible question is then 
how these exposures can be reduced?  
 
4.7.1 Treatment  
Mental disorders can be treated both with psychotropic medication and psychotherapy. 
Antidepressants in general have effect in about two thirds of patients in clinical trails (266). 
Selective Serotonin Reuptake Inhibitors (SSRI) have been demonstrated effective in 
depression, but it is not known if this effect is specific for SSRIs or if similar effect is 
attainable through other classes of antidepressive medication (267). Medication originally 
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designed for treating depression is also shown effective in treating anxiety disorders, however 
not as effective as in treating depression (268, 269).  
 Also psychotherapy is an effective treatment in mental disorders (270), in particular 
cognitive behavioural therapy (CBT) is well documented as an effective treatment for 
depression and anxiety disorders (271, 272). Some studies indicate that CBT is more effective 
than expected effect from treatment with psychotropic medication alone (273, 274). In mild 
and moderate depression, psychotherapy has been shown equally effective as medication 
(275), and more effective than medication in treatment of anxiety disorders (276).  
 It is estimated that maximally half of the burden of common mental disorders in young 
people can be averted with existing psychological and pharmacological treatment methods 
given maximum coverage (the number of people seeking treatment), clinical competence, and 
patient compliance to treatment (277). However, these presumptions are at present not by far 
met. Theoretically, inspired by the filters to treatment by David Goldberg (278, 279), the total 
effect on the mental health of the population, by means of all mental health care comprised, 
can be estimated as the product of five proportions: (i) The proportion of the population that 
seek professional help (for anything, usually seeing GPs for physical complaints); (ii) The 
proportion of cases of mental conditions detected in primary care; (iii) The proportion of 
detected cases offered treatment (either in primary care or by referral); (iv) The proportion of 
patients offered treatment that comply and complete the treatment; and (v) the effect of the 
treatment offered. Being realistic, or perhaps even optimistic, presuming all these proportions 
to be 50%, the total effect of treatment on the mental health of the population is 3%. A 
limitation to this theoretical model is the presumption that all five proportions are 
dichotomies.  
Almost the entire attention in education of psychiatrists and psychologist is at the fifth 
level (effect of treatment). The cost effectiveness of further development of interventions 
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delivered in mental health care of the general population is perhaps better in any of the four 
first levels rather than the fifth. However, money (both in pharmaceutical industry and public 
funds for research) are generally more easily raised for research on effects of treatment rather 
than the first four filters to treatment for mental disorders.  
 
4.7.2 Prevention  
The development of prevention programmes for mental disorders must be based on 
knowledge about the causes of mental disorders, and also factors that can promote and 
accelerate restitution and hinder relapse. Obviously, a whole range of factors do contribute to 
the development of mental disorders. There is also focus on resilience factors; factors 
protecting onset of mental disorders. A thorough model on these complex relationships 
providing good face value is offered by Goldberg and Goodyear and focuses on vulnerability, 
destabilisation and restitution as phases in the course of mental illness (280):  
 Vulnerability is defined as a process that increases the probability for mental disorder 
but is in itself insufficient to cause a disorder (280). Vulnerability is found vertically, that 
means that it involves social, psychological, and neurochemical processes. Commonly, each 
factor that increases the vulnerability carries little risk, but risk factors are often clustered in 
groups. For example, in families where childhood sexual abuse occur, other family 
background risk factors are also increased, both independently increasing psychopathology in 
the victims in adult life (281, 282).  
 Genes account for about 40% of the determinants and symptoms of both anxiety and 
depression, most likely resulting from multiple recessive genes. The location of these genes is 
still a matter of conjecture (280). It is unlikely that specific genes are controlling specific 
disorders. Genes associated with anxiety and depression is hypothesized to be shared (283), 
but there is evidence for specific genes responsible for vulnerability to disorders related to 
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fear like in panic and phobias (280). Goldberg and Goodyear suggest that genes associated 
with anxiety and depression mainly control emotional traits emerging through childhood, as 
fearfulness and shyness, rather than being specific for more complex states like anxiety and 
depression (280).  
A gene responsible for transporting serotonin labelled 5HTT gene found on paired 
chromosome 17 (17q11.2) can be either be of both long alleles, both short, and heterozygous. 
In a prospective longitudinal study, the individuals with homozygous short allele of the 5-
HTT promoter polymorphism (17% of the population) exhibited more depressive symptoms, 
diagnosable depression, and suicidality when exposed to stressful life events than individuals 
homozygous for the long allele as compared to the group with homozygous long alleles 
(31%). Heterozygous people responded to stressors in an intermediate fashion compared to 
the two homozygous groups' responses (284). The authors demonstrated a gene-by-
environment interaction, thus not merely an additive effect of genes and adverse environment, 
which is a far more common model in this literature. With reference to this gene, it has been 
suggested that gene environment interactions are particularly important in depression (280).  
The most important early environmental contribution to later anxiety an depression is 
the quality of maternal attachment (280). John Bowlby's seminal writings on the primary 
importance of the affectional bond between mother and infant (285) have generally been 
supported in e.g. follow-up studies of adopted children deprived in first living years (286). 
According to Bowlby, particular adults (most often the mother) function as a secure base for 
the infant. The emotional responsivity of the mother to the infant is hypothesized to result 
from evolutionary adaptation. Failure to develop optimal pair bonding may develop from 
either the caregiver or the infant, and might have adverse consequences in adult life (287). 
According to the Strange Situation experiment (where the child's responses to the mother after 
a brief separation is evaluated as secure or insecure), most children (65%) are securely 
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attached, and 35% show one of the subcategories of being insecurely attached (288). 
Numerous studies have shown that securely attached children develop better; they socialize 
more competently and are more popular with their peers (289). Secure attachment have also 
been reported to increase adaptation in more demanding social and educational worlds, 
including positive self-concept, high levels of attention and concentration, and good semantic 
memory.  
Maternal depression represents a risk to the child in many ways, including e.g. poor 
nutrition and general instrumental care, but might also influence mother-child attachment. 
Effects of mothers' depression on cognitive abilities in offspring are broadly reported in 9 to 
18 month olds, but seem to normalize at about 5 year of age (290). Children of depressed 
mothers have higher rates of aggression, hyperactivity, worry about self-efficacy and 
depressogenic cognitions at around age of 5 (287). Murray and colleagues observed that 5-
year-old offsprings of mothers with postnatal depression responded with negative statements 
about themselves when placed in circumstances involving an interpersonal challenge from 
another child that may involve potential failure (287). There is strong evidence both from 
studies on humans and animals that early deprivation causes changes in the sensitivity of the 
Hypothalamic-pituitary-adrenal (HPA) axis (280).  
Vulnerability for mental disorders is also shaped during childhood and adolescence. 
Effects of poor parenting practices are, however, less dramatic than poor attachment. The list 
of risk factors for later incidence of mental disorders is long, including marital discord, failure 
to develop friendships and sexual abuse. In adolescence, being unpopular with peers seems to 
be a risk factor for later development of psychopathology, particularly among girls (280).  
Destabilisation is the label used by Goldberg and Goodyear to describe the effect 
stressful life events or major social difficulties, commonly preceding onset of depressive or 
anxious symptoms (280). Their vulnerability-destabilisation-restitution model suggests that 
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the threshold for developing symptoms of anxiety and depression is roughly inversely 
proportional to the level of vulnerability (that is, the severity of the childhood adversity). 
However, with sufficiently severe stress, symptoms can develop in the absence of earlier 
adversity.  
Restitution, again according to Goldberg and Goodyear's model (280), refers to 
recovery from case-level anxiety or depression. Spontaneous recovery without treatment is 
common, but will often be followed by relapses.  
 Prevention programmes for anxiety and depression can be developed and directed at 
all the suggested elements in the vulnerability-destabilisation-restitution model. It follows 
from this model that a child with low vulnerability (e.g. good maternal attachment, no abuse 
or maltreatment, friends during childhood and adolescence, etc.) will be resilient to later life 
stress. High self-confidence and self-esteem, a repertoire of social problem-solving 
approaches, a secure stable affectionate relationship with another person, and experiences of 
success and achievement are all key features of resilience (291).  
The aims of preventive programmes are to reduce incidence of mental disorders 
through reducing vulnerability factors, reduce factors that causes destabilization of vulnerable 
individuals, and to facilitate restitution. Genes and early dysfunctional maternal attachment 
are among vulnerability factors not easily reached.  
Prevention of mental disorder can be primary as in aimed at the general population 
(again divided into those with universal versus selective measures), secondary as in aimed at 
groups presumed to be at risk for development of mental disorders, or tertiary as in aimed at 
prevention of further consequences of manifest disorders (292).  
Primary prevention aims at hindering the disorder to occur at all. Universal measures 
in primary prevention aim at lowering the general level of symptoms in the entire population, 
and interventions are generally on a political level (291). An example of a successful primary 
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intervention more or less specific for Norway is the high prices on alcohol, which is a likely 
explanation as to the lower prevalence of alcohol dependence in Norway (7) compared to the 
US population (8), a difference not found for other mental illnesses. The preventive effect of 
taxation on alcohol is, however, restricted by the growing economic wealth. An example from 
the UK, is the recent public debate on whether physical punishment of children should 
become banned. Goldberg and Goodyear summarizes a series of successful primary 
preventions through universal measures (291): Suicide rates have been found to be reduced by 
limiting the way suicide is reported in the media; prevention programmes in schools aimed at 
reducing drug use have been demonstrated as effective; victimisation and bullying is reduced 
by whole-school interventions employing the Olweus programme; brief educational 
programmes aiming at improving parenting are shown effective; and school-teacher delivered 
fully manualized CBT programmes have been demonstrated impressive results in the short 
term, but not at one year follow-up.  
Some risk factors are only marginally attainable within political measures, but are 
merely a result of political climate in the population: Association between conservative 
governments and suicide have been reported (293, 294). Many indicators of health have been 
shown to be associated with socioeconomic class (149, 150, 157).  
Many primary prevention programmes employing selective measures have been found 
relatively successful, and Goldberg and Goodyear lists some that have produced evidence for 
their efficacy (291): Home visits by health visitors have been shown to prevent postnatal 
depression. Pregnant women at risk visited by trained nurses on nine occasions during 
pregnancy reduced verified cases of child abuse in addition to numerous other benefits 
(reduced smoking during pregnancies, fewer pre-term deliveries and a reduction of reported 
sexual abuse).  
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An example of a secondary prevention programme is routine early psychological 
debriefing after exposure to trauma. There exist few randomized controlled trails in this area, 
and some studies have indicated an adverse effect of these interventions (295-297). However, 
this example is an exception, as a meta-analytic review of prevention of incidence of new 
cases of mental disorders (mainly secondary and tertiary interventions) concluded with a 
general preventive effect of interventions aimed at mental disorders (298). A problem in 
studies of prevention of incidence is the lack of statistical power (299), and as a consequence, 
the number of good studies is limited.  
As to tertiary prevention, most efforts have been invested on faster recovery and 
preventing relapses. Most depressions respond to simple measures like single antidepressants 
or problem-solving therapy, but a little more than one in four will need CBT by specifically 
trained clinicians, often in combination with various antidepressant drugs (291). However, 
resources available for delivering CBT are scarce, and the few are generally not provided to 
those needing them the most.  
In summary, there exist available preventive means for mental disorders on primary, 
secondary and tertiary levels. However, far more resources and expertise is invested in 
treatment of mental disorders than prevention. (This problem corresponds to that of the many 
filters to treatment discussed in the preceding chapter 4.7.1, where almost all effort is invested 
in further development of fairly effective means, but not on the under-recognized problems of 
bringing individuals in need into treatment in the first place). Most well educated psychiatrists 
and psychologists would agree that preventive measures give far more value for money in 
terms of public health spending; yet most invest their careers in treatment of single 
individuals. This might be explained by the way humans are motivated. As formulated by 
Jennifer Newton (300): "… there is the issue of motivation. Clinicians are trained to respond 
to clinical problems and invariably gain satisfaction from doing their best to make ill people 
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well. Where a problem is not already manifest, there is not much satisfaction to be derived 
from developing anticipatory actions to prevent something that in any case might not. And 
there is no feedback to reward the practitioner for his efforts as there is when an ill person 
recovers [… ] While the value of cures for distressing and life-threatening illnesses is 
apparent to everyone, what person stops to think about the illnesses they have avoided?"   
 
4.8 Future research  
4.8.1 Disability pension award  
The general question of why some individuals become disability pensioners while others do 
not is not well answered in the existing literature (98, 110). The significance of health is 
questioned with reference to the inverse association between changes in key public health 
indicators and incidence of disability pension. There is strong evidence for an impact of health 
on disability pension award from the disability pension paper, though more so from somatic 
symptoms (rather than diagnoses) and mental health. In the same paper, there is strong 
evidence for risk-factors of relevance beyond health, including age and educational level. At 
present, 12% of the Norwegian population within working age is recipients of disability 
pension, representing a large financial burden to society and a potential threat to welfare 
systems as we know them today. The very most is yet to be understood in relation to disability 
pension, and the disability paper inspires three major questions:  
The first main question concerns how poor health increases disability pension award: 
(i) From the parsimonious model in the disability pension paper, somatic diagnoses seems to 
be more loosely related to disability pension award than somatic symptoms (both being 
adjusted for the other). However, according to regulations, all applications for disability 
pension must be accompanied by a medical certificate confirming presence of a diagnosis 
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causing work-related impairment. Consequently, statistics based on medical certificates will 
be biased in the direction of diagnoses at the cost of more vague symptoms. This discrepancy 
between the impact of somatic diagnoses and somatic symptoms needs further attention. (ii) 
Further, sickness presence (defined as continuing work despite health problems) is highly 
prevalent, which is also sickness absence without any illness or disease (301). We know little 
about reasons for, and consequences of, sickness presence and this needs further attention. 
(iii) Subjective components such as health beliefs, sick roles and attributions about own health 
need more attention, as they might contribute substantially to the risk of disability pension and 
sickness presence, and they might also influence prospects of return to work in shorter 
absences. (iv) Preliminary findings from an ongoing study suggest under-treatment for mental 
disorders prior to disability pension award for a F-diagnosis (262). A clinical interview-based 
study of individuals recently awarded disability pension should be performed with the 
purpose of determining the quality of treatment offered. From these preliminary findings 
based on epidemiological data and self-report, as well as knowledge on the quality of case-
finding and treatment offered in primary care, it might be fair to hypothesize a substantial 
potential in preventing disability pension awards.  
The second main question that needs further attention is risk factors for disability 
pension award beyond health. According to public statistics, all disability pensions are caused 
by a diagnosable medical condition (30). As discussed in chapter 1.3.4, macro-economic 
factors influence disability pension award (111, 142), and the parsimonious model indicated 
strong and independent effects of age and educational level. Specific objectives to be further 
examined in this are many, but the following four seem imperative: (i) How large proportion 
of disability pension awards represents processes of medicalization? In other words, how 
strong is the independent effect of push-factors on a societal level compared to the 
independent effect of health in prediction of disability pension award, and what proportion of 
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such effects are overlapping? (ii) There are multiple reports of effects of social class, both 
defined by educational level and type of job (149, 152, 153). As corresponding social 
inequalities in health are reported (157), it is plausible that health is a mediator of the 
association between socioeconomic status and disability pension award. Competing 
hypotheses beyond health on the mechanisms underlying associations between socioeconomic 
status and disability pension award include both push-factors (being excluded from the labour 
marked) and pull-factors (finding disability pension a viable and attractive alternative to work 
as a source of income). The mechanisms underlying the effect of socioeconomic status and 
disability pension award thus need further attention. (iii) The pull-model hypothesizes a 
positive association between disability pension award and economic incentives for this. 
Economic incentives for disability pension can be operationalized as the ratio between the 
potential income from disability benefits and current level of income. There is some support 
for this hypothesis (143, 144, 156), but none of the relevant studies have accounted for the 
possible confounding by health which is a major shortcoming due to the following: Low 
socioeconomic status is associated with both high relative compensation from a potential 
disability pension, and at the same time poor health. The question of whether public welfare 
schemes are attracting individuals from work is on the political agenda both in Norway (156) 
and in other OECD countries (134, 143). These issues can be addressed empirically by 
employing data from HUNT-2 in record linkage with public registries of work, tax, income 
and pension (155).  
The third main question concerns whether being awarded disability pension improves 
or deteriorates health (hence discussion in chapter 1.3.2). We know very little about 
consequences of being a recipient of any long-term disability benefit (110). Two divergent 
positions both seem plausible: Disability pension might deteriorate health through reduced 
physical activity, isolation, stigma and loss of work-role; or improve health through relief 
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from work-related strains and burdens, and relief from financial worries in cases where 
marginalization from the labour marked is present. Randomized controlled trails is obviously 
impossible due to ethical concerns, but a longitudinal approach might be an option with 
baseline health data from HUNT-2, sub-sequent exposure in the disability pension registry, 
and outcome in the mortality registry, or by self-report of health status in HUNT-3 (in 2007).  
 
4.8.2 Mortality  
As introduced in chapter 1.4.4 and discussed in chapter 4.6.1, the two mortality papers 
addressed six questions. The analyses have added evidence to some questions, and raised 
others:  
(i) The first issue concerned residual confounding in the association between 
depression and mortality (169). As discussed above in chapter 4.3.2, residual confounding 
will always be an issue. However, our analysis is adjusted for a number of somatic symptoms 
and conditions, so it is unlikely that the effect of depression on mortality is confounded by 
somatic conditions not accounted for in the model. Consequently, the issue of residual 
confounding is perhaps not the first in need of attention in this field.  
(ii) We have provided new evidence for a dose-response association between severity 
of depression and mortality, which might be an issue for future replications.  
(iii) Our analyses might inspire new approaches for identifying mechanisms 
underlying the association between depression and mortality. The finding that depression 
predicts CVD mortality equally strong as mortality from other causes comprised, does not 
exclude the existence of specific biological mechanisms for CVD and other causes of death; 
we cannot exclude the possibility of separate biological mechanisms with equal effect size 
underlying each mortality diagnosis. However, the finding does increase the relevance of 
searching for common mechanisms across mortality diagnoses. For CVD mortality, candidate 
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mechanisms proposed include antidepressant cardiotoxicity, lower heart rate variability 
reflecting altered cardiac autonomic tone, and increased platelet aggregation (191). Our 
analyses explored possible biological mechanisms through including BMI, cholesterol level, 
and blood pressure, and none of these accounted for the association.  
Socioeconomic differences in health (150) did account for some of the association. 
Further, we found support for the hypothesis that health related behaviours found in 
depression also could account for some of the association. We were, however, only able to 
adjust for available data on health related behaviour, which comprised physical activity, 
smoking and alcohol problems (CAGE). These three factors are not covering all aspects of 
health-related behaviour related to depression, as factors like nutrition, sleeping patterns, 
physical activity beyond exercise and help-seeking behaviour were not covered, and might all 
be candidate mechanisms for explaining the association. Furthermore, residual confounding 
from health related behaviour is likely, as the three included aspects of health-related 
behaviour are measured with single or few items only (details in chapter 2.4.5). As discussed 
in chapter 4.5.1, there might be particular problems of validity relevant when measuring 
alcohol problems through CAGE, which further increase the likelihood of residual 
confounding.  
 (iv) We provide new findings relevant for the question of which mortality diagnoses 
are associated with depression. These findings inspire new questions: We found an effect of 
depression on all causes of mortality except mortality from gastrointestinal causes (N=47, 2% 
of deaths during follow-up) and for a residual category (N=71, 3%) comprising certain 
infectious and parasitic diseases, diseases of the musculoskeletal system and connective 
tissue, diseases of the genitourinary system, congenital malformations, deformations, and 
chromosomal abnormalities. As the power in prediction of mortality in these small groups is 
low, we cannot exclude type 1 error, but non-significant effects in these groups did not 
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indicate any effect of depression. Whether depression predicts disease mortality in general, or 
if there are exceptions, is yet to be answered.  
 Our finding that the effect of depression is equally strong in CVD mortality as 
mortality from other causes comprised is new, and replications applying other data sources 
are needed. Most available health surveys will, however, lack the sufficient statistical power 
to provide a necessary baseline for this purpose, and few countries provide personal 
identification numbers that can be applied for identification of mortality in public registries.  
 Cancer is the second largest cause of death, and it is not clear from the literature 
whether depression increases cancer mortality. An extensive review examined if 
psychological factors cause cancer (302). Despite certain intriguing findings warranting 
further studied, the authors concluded that the evidence failed to support the hypothesis that 
depression was a risk factor for cancer. The same group of researchers reached the same 
conclusion in a large registry-based study of patients hospitalized for affective disorders 
(303), and psychosocial interventions have not been found to increase survival in cancer 
patients (304). There are, however, some reports of effects of depression on mortality in 
selected groups of cancer patients (305, 306). Our finding of increased cancer mortality in 
depression is therefore in need of replications. However, our finding of equal effect of 
depression in CVD mortality and other causes combined suggests that future attempts of 
examining mechanisms driving the association should not be restricted to hypotheses relevant 
for cancer mortality only.  
 As presented above, we employed the underlying cause of death (as described in 
chapter 1.4.2) for the purpose of categorization in predicting cause specific mortality. Other 
mortality diagnoses might be relevant in further explorations of mortality from depression. 
Mortality diagnoses beyond underlying cause of death might also represent an issue of 
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confounding or misclassification, for example represented by comorbid CVD in cases where 
cancer or respiratory diseases are encoded as underlying cause of death.  
We found an effect of comorbid anxiety and depression in both mortality from 
accidents (N=80) and mortality without medical certificate for cause of death (N=40), a 
pattern similar to that of suicide (N=29). The effects were, however, weaker and non-
significant after adjustment for possible confounding or mediating factors. It is unclear what 
these effects represent: Possible hypotheses include hidden suicides among non-illness deaths 
(caused by bias in direction of under-report of suicide in unclear cases), increased hazardous 
behaviour, or perhaps also other causes.  
(v) The issue of effect-moderation by gender might be settled from our analyses, but 
replication employing other measures of depression than HADS might be useful, as when 
employing HADS, prevalence estimates of depression diverge from other measures by being 
equal in men and women (77). Evidence of effect-moderation of gender with proper testing 
for interactions (rather than reports based on stratified analyses) are lacking (169). We have 
no explanation of the stronger effect of depression on mortality in the younger part of the 
population, which adds to the issues in need of further attention.  
(vi) Our finding of a U-shaped effect of anxiety on mortality is novel. The effect of 
low anxiety (first quartile, compared to third) accounts for far more mortality than does case-
level depression. (Whether adverse consequences of low levels of symptoms of 
psychopathology belong to the field of mental health is uncertain; symptom rating scales like 
HADS are usually scaled from good health to psychopathology, and in this case, the adverse 
outcome is most strongly associated with what we usually regard as good health.) Obviously, 
it would be interesting to examine the effect of low anxiety in relation to cause specific 
mortality, and also to examine confounding and mediating factors in more detail. A plausible 
hypothesis is that low anxiety predicts accidents, as it can be argued that at least some 
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minimum level of anxiety aids survival. However, as non-illness mortality is relatively rare, 
this can probably not account for the entire effect.  
In combination, the findings of lower mortality in comorbid anxiety and depression 
than in depression alone, higher mortality in low anxiety than medium levels, and high 
mortality in depression actualize a hypothesis of anxiety and depression being proxies of 
activation level, which again is positively associated with mortality. Continuing this line of 
argumentation, low level of activation would be indicated by high depression and low anxiety 
(and indeed both), whereas high level of activation would be found in high anxiety without 
depression.  
 
4.9 Conclusion  
Employing a historical cohort design, we utilized unique links between a large 
epidemiological cohort study (the HUNT-2 study) and comprehensive national databases of 
disability pension award and mortality.   
Anxiety and depression were robust predictors of award of disability pensions in 
general, and also for awards for alleged non-psychiatric conditions according to the 
applications for disability pension. Depression predicted general mortality, also after 
adjustment for multiple confounding factors. Associations between anxiety symptoms and 
mortality were U-shaped. The effect of depression on mortality was not limited to CVD 
mortality and suicide, but included most disease-mortality, and also non-illness deaths beyond 
suicide. Lower mortality was found in comorbid anxiety and depression than in depression 
alone in disease mortality. On the contrary, suicide was associated with comorbid anxiety 
depression rather than depression alone. The marginal effect of case-level anxiety on 
mortality was entirely explained by adjustment for depression.   
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 Somatic symptoms were also strong predictors of disability pension award, and did 
also account for much of the effect of anxiety and depression. In contrast, somatic diagnoses 
were strong predictors of mortality, and accounted for much of the effect of depression on this 
outcome.   
 The finding that anxiety and depression predict disability pension awarded for non-
psychiatric diagnoses indicates that the cost of common mental disorders in terms of disability 
pension and lost productivity may have been considerably underestimated by official 
statistics. The finding that depression increases mortality beyond CVD mortality and suicide 
might be yet another indication of underestimation of the consequences of depression.  
 On the individual level, anxiety and depression can be reduced by psychotropic 
medication and psychotherapy. Despite the existence of quality treatment for anxiety and 
depression, only a minor proportion of the population with common mental disorders will 
ever find their way to treatment. Combined with variable quality of treatment as usual, the 
impact of treatment on common mental disorders of the population is marginal. Several 
preventive treatment strategies are found to have good effect, but resources are generally 
spent on treatment rather than prevention. There exists a potential for reduction of anxiety and 
depression in the population by improved treatment strategies and prevention.  
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